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Abstract
The completion of the Human Genome Project revealed the sequence identity of essentially every human
protein. However, in most cases, amino acid sequences alone convey little implication on the protein static
structures, its dynamic conformational changes, and most importantly, its functions. To fully understand the
behaviors and properties of macromolecular complexes, solving their 3D structures is necessary and highly
critical. Under this rationale, structural genomics collaborations were initiated aiming to determine high-
resolution structures of as many proteins and protein folds as possible, relying mostly on X-ray crystallography
and NMR spectroscopy. Yet, very large, highly flexible or disordered, and dynamic protein complexes can
exceed the capabilities of these high-resolution techniques. Although computational molecular modeling can
be utilized, such structures are highly speculative and often inaccurate unless supported by actual
experimental data. Structural mass spectrometry recently emerged as an alternative method which can
provide medium-resolution spatial information capable of complementing computational approaches, and are
applicable to heterogeneous samples with potentially no limit on complex sizes. In particular, chemical
crosslinking coupled with mass spectrometry, has recently received considerable interest. Most recent
progress focused on developing crosslinkers with special properties such as enrichment tags, isotopic labeling
sites, or MS-cleavable bonds along with accompanying data analysis strategies and software packages. These
crosslinkers insert their spacer arm between proximal amino acid residues, greatly reducing the stringency of
the derived distance constraints. In contrast, "zero-length crosslinkers" are crosslinks which do not add any
extra atoms to the product crosslinked peptides, therefore providing the tightest possible spatial constraints
but rendering enrichment and isotopic labeling strategies inapplicable. As a result, zero-length crosslinking
received limited attention and no software tools have previously been specifically developed for it.
In this thesis project, we developed a multi-tiered mass spectrometry data acquisition and computational data
analysis strategy along with a dedicated software tool to enhance identification of zero-length crosslinks in
complex samples. Label-free comparison and targeted high-resolution mass spectrometry were utilized to
filter out the vast majority of non-crosslinked peptides and increase confidence of crosslink identification,
compensating for the lack of enrichment techniques and characteristic MS patterns employed by non-zero-
length crosslinking methods. Each step from mass spectrometer acquisition parameters to MS/MS spectra
evaluation functions was optimized based on zero-length crosslinking datasets of proteins with known crystal
structures. Our pipeline was then applied to probe structures and conformational changes of mini-spectrin, a
90 kDa recombinant protein that closely mimics erythrocyte spectrin's dynamic dimer-tetramer equilibrium.
Compared to previous analyses performed in our laboratory, the current strategy more than doubled the
number of identified crosslinks and significantly reduced analysis time per experiment from months to just
several days. Distance constraints derived from mini-spectrin crosslinks were used as inputs in subsequent
homology modeling, allowing development of experimentally-verified medium-resolution structures for wild-
type mini-spectrin tetramer and both wild-type and hereditary elliptocytosis (HE) mutant mini-spectrin
dimers. The structure models, in combination with independent biophysical experiments, illustrated how
such distal HE-related mutations destabilized spectrin dimer-tetramer equilibrium by simultaneously
lowering thermal stability of tetramer and giving rise to a more-compact, more-stable closed dimer
conformation.
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ABSTRACT 
IN-DEPTH ANALYSIS OF ZERO-LENGTH CROSSLINKING FOR 
STRUCTURAL MASS SPECTROMETRY 
Sira Sriswasdi 
David W. Speicher, Ph.D. 
The completion of the Human Genome Project revealed the sequence identity of 
essentially every human protein. However, in most cases, amino acid sequences alone 
convey little implication on the protein static structures, its dynamic conformational 
changes, and most importantly, its functions. To fully understand the behaviors and 
properties of macromolecular complexes, solving their 3D structures is necessary and 
highly critical. Under this rationale, structural genomics collaborations were initiated 
aiming to determine high-resolution structures of as many proteins and protein folds as 
possible, relying mostly on X-ray crystallography and NMR spectroscopy. Yet, very 
large, highly flexible or disordered, and dynamic protein complexes can exceed the 
capabilities of these high-resolution techniques. Although computational molecular 
modeling can be utilized, such structures are highly speculative and often inaccurate 
unless supported by actual experimental data. Structural mass spectrometry recently 
emerged as an alternative method which can provide medium-resolution spatial 
information capable of complementing computational approaches, and are applicable to 
heterogeneous samples with potentially no limit on complex sizes. In particular, chemical 
crosslinking coupled with mass spectrometry, has recently received considerable interest. 
Most recent progress focused on developing crosslinkers with special properties such as 
enrichment tags, isotopic labeling sites, or MS-cleavable bonds along with accompanying 
data analysis strategies and software packages. These crosslinkers insert their spacer arm 
between proximal amino acid residues, greatly reducing the stringency of the derived 
distance constraints. In contrast, “zero-length crosslinkers” are crosslinks which do not 
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add any extra atoms to the product crosslinked peptides, therefore providing the tightest 
possible spatial constraints but rendering enrichment and isotopic labeling strategies 
inapplicable. As a result, zero-length crosslinking received limited attention and no 
software tools have previously been specifically developed for it. 
In this thesis project, we developed a multi-tiered mass spectrometry data 
acquisition and computational data analysis strategy along with a dedicated software tool 
to enhance identification of zero-length crosslinks in complex samples. Label-free 
comparison and targeted high-resolution mass spectrometry were utilized to filter out the 
vast majority of non-crosslinked peptides and increase confidence of crosslink 
identification, compensating for the lack of enrichment techniques and characteristic MS 
patterns employed by non-zero-length crosslinking methods. Each step from mass 
spectrometer acquisition parameters to MS/MS spectra evaluation functions was 
optimized based on zero-length crosslinking datasets of proteins with known crystal 
structures. Our pipeline was then applied to probe structures and conformational changes 
of mini-spectrin, a 90 kDa recombinant protein that closely mimics erythrocyte spectrin’s 
dynamic dimer-tetramer equilibrium. Compared to previous analyses performed in our 
laboratory, the current strategy more than doubled the number of identified crosslinks and 
significantly reduced analysis time per experiment from months to just several days. 
Distance constraints derived from mini-spectrin crosslinks were used as inputs in 
subsequent homology modeling, allowing development of experimentally-verified 
medium-resolution structures for wild-type mini-spectrin tetramer and both wild-type and 
hereditary elliptocytosis (HE) mutant mini-spectrin dimers. The structure models, in 
combination with independent biophysical experiments, illustrated how such distal HE-
related mutations destabilized spectrin dimer-tetramer equilibrium by simultaneously 
lowering thermal stability of tetramer and giving rise to a more-compact, more-stable 
closed dimer conformation. 
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Chapter 1: Introduction and Background 
The completion of the Human Genome Project revealed the sequence identity of 
essentially every human protein. However, in most cases, amino acid sequences alone 
convey little implication on the protein static structures, its dynamic conformational 
changes, and most importantly, its functions. To fully understand the behaviors and 
properties of macromolecular complexes, solving their 3D structures is necessary and 
highly critical. Under this rationale, structural genomics collaborations were initiated 
aiming to determine high-resolution structures of as many proteins and protein folds as 
possible, relying mostly on X-ray crystallography and NMR spectroscopy. Yet, very 
large, highly flexible or disordered, and dynamic protein complexes can exceed the 
capabilities of these high-resolution techniques. Although computational molecular 
modeling can be utilized, such structures are highly speculative and often inaccurate 
unless supported by actual experimental data. Structural mass spectrometry recently 
emerged as alternative methods that can provide medium-resolution spatial information 
capable of complementing computational approaches, and are applicable to 
heterogeneous samples with potentially no limit on complex sizes. In particular, chemical 
crosslinking coupled with mass spectrometry, has recently received considerable interest 
mainly due to the recent developments of modern mass spectrometers with higher mass 
accuracy, resolution, duty-cycle, and sensitivity. 
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1.1 Structural Mass Spectrometry 
 The use of mass spectrometry (MS) to probe structural information of 
macromolecular complexes provides distinct advantages over high-resolution structural 
determination techniques due to the fact that MS-based methods are much more tolerant 
of heterogeneity and impurities in the samples, can detect dynamic, transient interactions, 
and is less limiting in terms of protein complex size and abundance (1-5). Although MS-
based structural techniques provide only medium-resolution spatial constraints, they can 
be used to complement computational molecular modeling and other conventional 
structural determination methods, facilitating assembly of high-resolution subunit 
structures into large complex models (6-7). Structural MS approaches consist of top-
down strategies that provide information on intact macromolecules and bottom-up 
approaches which translate modified amino acid sites into solvent accessibility or residue 
proximity data, each with its own strengths and weaknesses. 
 Ion mobility MS (IM-MS) (8-9) is a dominant top-down technique that translates 
travel time of protein complex molecules in an electric field into collisional cross sections, 
which are related to the shape and size of their 3D structures. IM-MS can be used to 
probe the number and relative abundance of distinct, simultaneously occurring 
conformations of protein complexes, and is capable of analyzing intact large-scaled 
systems (10-12). Limitation of IM-MS includes the facts that the protein complex 
integrity has to be stably preserved in gas-phase for analysis by MS and that the method 
is only appropriate for detecting whole-complex-scale conformational changes. While 
bottom up methods focus on peptide identification and therefore have no such physical 
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limitations, they rely heavily on the performance of downstream analysis strategies to sift 
through the data for low abundance modified peptides. For example, hydroxyl radical 
footprinting (13-14) modifies amino acid side chains with hydroxyl radicals generated 
from hydrogen peroxide or irradiated water molecules, and peptides containing these 
modifications are then identified using bottom-up MS. Since only solvent-accessible 
regions of the molecule can be penetrated and labeled with hydroxyl radicals, this method 
can recognize changes in protein surface topology and identify protein-ligand binding 
interface. Complication of this technique centers on the facts that virtually every amino 
acid can be modified, though the ranking of relative activity has been established, and a 
number of them even result in multiple characteristic modifications (15-17). This 
combinatorial expansion in search space can easily jeopardize the quality of peptide 
identification. Hydrogen-deuterium exchange (HDX) (18-19) operates under the same 
premise as hydroxyl radical footprinting but instead relies on modifying backbone atoms 
with deuterium-containing water molecules (D2O as opposed to H2O). HDX is a hybrid 
technique that can be used to both detect global changes in deuterium incorporation of 
intact protein complexes and identify local solvent-accessible regions via bottom-up MS. 
In addition to common drawbacks, HDX also suffers from back-exchange (deuterium-
labeled sites reverting back to hydrogen), requiring rapid MS analysis and restrictive 
sample preparation conditions. 
 Another major bottom-up approach is chemical crosslinking (20-24), which 
provides spatial constraints between proximal amino residues by inducing covalent bond 
between them. This technique became our method of choice because it can generate 
distance constraints essentially throughout the entire protein complex’s structure and is 
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most suitable for guiding and validating computational molecular modeling. As a bottom-
up approach, major bottlenecks for chemical crosslinking and zero-length crosslinking in 
particular, mainly involve the complexity of downstream data analysis and crosslinked 
peptide identification. 
1.2 Chemical Crosslinking 
The concept of chemical crosslinking has been around since as early as 1971 (25) 
but it was not until the mid-1990s that mass spectrometry became available for the 
analysis of peptides and proteins, greatly expanding the utility of chemical crosslinking 
(26-27). Prior to that, most studies had to rely on gel-based methods to detect mass-shifts 
or changes in peptide profiles (28-29). During the past decade, advances in crosslinker 
design and mass spectrometry technology allowed chemical crosslinking to be effective 
on larger macromolecular complexes and biological systems (30-33). 
 In its simplest form, chemical crosslinking introduces bifunctional crosslinking 
reagents which interact with certain amino acid side chains in order to form a covalent 
bond between a pair of proximal residues. When setting up reactions, extreme care must 
be taken to ensure that only one crosslink, on average, forms on each molecule of the 
protein complex. Over-crosslinking occurs when the native structure of the protein is 
significantly altered by too many rigid, unnatural crosslinks, which enable formation of 
new artefact crosslinks. Consequently, crosslinking reactions are highly 
substoichiometric and yield very low abundance crosslink signals. Next, crosslinked 
samples are digested by proteases such as trypsin and subjected to MS analyses, and the 
peptides containing covalent crosslinked sites, “crosslinked peptides”, are identified. To 
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interpret crosslinked peptides as distance constraints, the chemistry involved and the 
spacer arm length of the crosslinking reagent used must be taken in account. For example, 
Disuccinimidyl suberate, or DSS, is a lysine-to-lysine crosslinker having a spacer arm 
length of 11.4 Å, and hence, each of the derived crosslinks defines an approximate 25 Å 
uncertainty between the alpha carbons of the two lysines involved. This is due to the 
length of the spacer arm and the two lysine side chains lengths (FIGURE 1-1). 
 
FIGURE 1-1 Crosslink-derived Cα-Cα distance constraints. 
Distance constraint between Cα atoms of the two crosslinked residues can be computed 
as the sum of amino acid side chain lengths and the crosslinker spacer arm. The 
calculation is approximative since dynamics of the molecules are taken into account. DSS 
is used for illustration here. 
 More than a hundred different crosslinkers are currently commercially available 
(Thermo Scientific / Pierce, Invitrogen, and Creative Molecules to name a few), most of 
them following the same basic design (FIGURE 1-2). Commonly utilized crosslinking 
reactivity can be roughly classified into amine-to-amine, carboxyl-to-amine, 
photoreactive, and those involving sulfhydryl function group on cysteine. The presence 
of a spacer arm allows addition of isotope labeling sites, MS- or chemical-cleavable 
bonds, and enrichment tags, all of which significantly reduce the complexity of 
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downstream data analysis, at the expense of longer crosslink distances. To utilize 
isotopically labeled crosslinkers, the “heavy” crosslinked sample derived from the 
isotopically labeled version the crosslinker and the “light” crosslinked sample derived 
from the non-labeled form are mixed at 1:1 ratio prior to MS analysis. As a result, each 
true crosslinked peptide appears as a heavy-light pair with roughly similar abundance 
while non-crosslinked peptides are present as single species. This discrepancy allows 
crosslinked peptide precursors to be selected for further analyses with high specificity. 
One such strategy additionally compares fragmentation patterns of the heavy and light 
versions of the same crosslink in order to distinguish between linear and crosslinked 
fragmented ions (34). 
 
FIGURE 1-2 Basic crosslinker design. 
The spacer arm provides a scaffold for incorporating isotope label sites, labile bonds, and 
enrichment tags. 
 Crosslinkers with MS-cleavable sites contain labile bonds that dissociate upon 
low-energy fragmentation inside the mass spectrometer and cause either the release of 
reporter ions to designate crosslink-specific MS/MS spectra (35) or the separation of the 
two peptide backbones of a crosslink to generate two MS3 spectra of non-crosslinked 
peptides that can be straightforwardly annotated (36). Another class of crosslinkers 
contains enrichment tags that permit specific purification of crosslinked peptides, 
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simultaneously reducing the complexity of the crosslinked samples and raising the 
concentration of crosslinked peptides. Some crosslinkers even combine several of these 
features (37). The main drawback of crosslinkers that utilize any of the aforementioned 
functionalities is the fact that their spacer arm (generally >10 Å) needs to be incorporated 
into the crosslinked product, greatly diminishing the power of derived distance 
constraints in validating and refining molecular modeling results (FIGURE 1-3). Also, the 
lysine-lysine chemistry involved frequently generated stable dead-end and self-loop 
products (38), further complicating crosslinked samples. 
 
FIGURE 1-3 Power of crosslink-derived distance constraints on molecular modeling. 
As more distance constraints are used to restrain molecular modeling of a protein 
structure, the accuracy of the model (RMSD) greatly improves. Moreover, crosslinks 
derived from crosslinkers with shorter spacer arm lengths are much more effective. Zero-
length crosslinkers correspond to the 9 Å trend. Image adapted from (21). 
 In contrast, zero-length crosslinkers do not add any extra atoms to crosslinked 
products, yielding the most stringent distance constraints. 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimidedo (EDC or EDAC), a dominant zero-length 
crosslinker for protein study and the focus of our work, induces formation of direct 
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peptide bond between primary amines of lysine or the protein N-terminal to carboxyl 
groups on glutamate, aspartate, or the protein C-terminal (FIGURE 1-4). However, the 
uses of aforementioned enrichment and detection strategies which require incorporation 
of parts of the crosslinker molecules into the products become inapplicable. As a result, 
relatively few studies utilized zero-length crosslinking and most systems under 
investigation were much smaller than 100 kDa equivalent of protein sequence complexity. 
Moreover, manual analysis or combinations of multiple software tools were required to 
process MS data and identify crosslinks (TABLE 1-1). Although a few software packages 
originally developed for non-zero-length crosslinking can be adapted to process zero-
length crosslinking datasets, many of them over-commit to the premise of lysine-lysine 
crosslinking chemistry and the common usage of low-resolution MS/MS data (39). For 
example, CrossWork (40) strictly operates on built-in definitions of popular lysine-lysine 
crosslinkers while MassMatrix (41-42), originally developed for disulfide bond detection, 
accepts user-defined crosslinkers but only allows single-residue-to-single-residue 
definitions of crosslinking reaction. Only pLink (43) contains an option for ppm-level 
mass tolerance for evaluating high-resolution MS/MS spectra. 
Most importantly, the fact that EDC-derived crosslinks form via a direct peptide 
bond implies that the mass of a crosslink between adjacent peptides of a protein is exactly 
the same as the mass of a long, uncleaved linear peptide (FIGURE 1-5). In many cases, 
these two isobaric possibilities produce largely indistinguishable patterns of fragmented 
b- and y-ions. Not properly considering alternative linear peptide explanations will result 
in false positive crosslinks. Since this complication does not occur when crosslinking 
between lysine residues, several software tools fail to recognize it, instead focusing only    
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FIGURE 1-4 Crosslinking chemistry of EDC. 
Image adapted from Thermo/Pierce website. EDC, supported by Sulfo-NHS, induces 
direct amide bond between two amino acid side chains without adding any extra atoms. 
 
Year Complexity (kDa) Software Tools Reference 
2010 50 Undisclosed (44) 
2010 124 Popitam (45) (46) 
2010 81 GPMAW (47) (48)* 
2010 91 GPMAW (49)* 
2011 16 MS2Links (50) (51) 
2011 58 
MassMatrix, Protein 
Prospector (52) 
(53) 
2011 16 Manual (54) 
2012 29 Manual (55) 
2012 19 MassMatrix (56) 
2012 73 Popitam, xComb (57) (58) 
2012 43 xComb, MS2Assign (38) (59) 
2013 32 MassMatrix, GPMAW (60) 
TABLE 1-1 Recent publications utilizing zero-length crosslinking. 
Complexity is based on non-redundant amino acid sequences, which is the effective 
complexity for mass spectrometry analysis. Entries marked with asterisk were analyzed 
in our laboratory using the previous analysis strategy. 
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FIGURE 1-5 Isobaric interpretations for crosslinking of adjacent peptides. 
TOP: Long, uncleaved linear peptide. BOTTOM: Crosslinked peptide. The two 
alternatives differ only by the locations of the highlighted amide bonds, resulting in 
identical masses. 
 
on the use of decoy crosslinked peptides. To the best of our knowledge, no group has 
developed a complete, dedicated data analysis software tool, especially one optimized for 
high-resolution MS/MS data, for zero-length crosslinking experiments. 
1.3 Mass Spectrometry 
 MS technology was first invented in 1912 by J.J. Thomson and it was in the late 
1980s when soft ionization methods, namely matrix-assisted laser desorption/ionization 
(61) and electrospray ionization (62), were developed which permitted MS analysis of 
biological molecules including peptides and proteins. About a decade later, high-
resolution, high mass accuracy Fourier transform mass spectrometers, FT-ICR (63) and 
the Orbitrap (64), were introduced. Improved mass accuracy in modern instruments 
greatly reduces the ambiguities of peptide mass assignments and therefore increases the 
confidence of identification (65). However, these improvements come at the cost of 
reduced scan speed, sensitivity, and consequently, depth of analysis compared to 
alternative low-resolution mass analyzers such as ion traps. To achieve a balance between 
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high mass accuracy and high depth of analysis, hybrid mass spectrometers, such as the 
LTQ Orbitrap XL (Thermo Scientific) used in our laboratory, couple an Orbitrap to a 
linear ion trap that is fast and sensitive but has low mass accuracy. This setup allows 
simultaneous measurements of accurate peptide precursor masses in the high-resolution 
mass analyzer (Orbitrap or FT-ICR) while obtaining a large number of MS/MS spectra 
with the fast linear ion trap. 
 Basic instrument setup for a proteomics experiment generally includes a front-end 
ultra-performance liquid chromatography (UPLC) which separates peptides based on 
their hydrophobicity and continuously feeds them into the mass spectrometer. The point 
in time from the sample injection to when a certain peptide eludes from the HPLC 
column is called its retention time. At each point in time, the mass spectrometer first 
acquires a full MS scan to determine mass-over-charge (m/z) and intensities of all signals, 
also called precursor ions. Then, according to the setup parameters, a certain number of 
the most abundance precursor ions are selected for fragmentation and MS/MS scans 
containing product ions were obtained (FIGURE 1-6). In practice, all ions within a small 
m/z window (typically ± 1-1.25 m/z unit, called “isolation window”) surrounding a target 
precursor are isolated for fragmentation. 
To identify peptides from MS/MS spectra, the first step is to determine accurate 
masses of the parent peptide precursors that gave rise to those spectra. Even though mass 
spectrometer measures only m/z ratios, because each peptide exists as a distribution of 
isotopes due to the existences of naturally occurring carbon-13, nitrogen-15, oxygen-18, 
and sulfur-34 species, charge state and, consequently, monoisotopic mass of each   
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FIGURE 1-6 Precursor isolation, peptide fragmentation, and MS/MS spectra generation. 
TOP: Precursor m/z corresponding to intense peaks in full MS scan are isolated and 
fragmented, giving rise to MS/MS spectra. BOTTOM: Each peptide bond can be 
fragmented, resulting in characteristic b-ions and y-ions. 
 
precursor ion can be determined from the m/z spacing between adjacent isotopes 
(FIGURE 1-7). Since full MS scans are generally obtained with a high-resolution mass 
analyzer, observed precursor masses can be searched against a database of peptide 
masses using stringent 5-10 parts per million (ppm) mass tolerance. Once matches are 
found, theoretical fragmentation patterns of b- and y-ions are generated and compared to 
the corresponding observed MS/MS spectra. False discovery rate is estimated by 
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performing the same search on a decoy database composed of reversed or randomized 
protein sequences. For the purpose of identifying linear peptides, low-resolution MS/MS 
data having mass accuracy on the order of ±0.5 amu or 250-2500 ppm is adequate. 
Furthermore, high-performance protein database searches and MS/MS spectra evaluation 
algorithms for linear peptides based on low-resolution MS/MS data are well-established 
(66-67). 
 
FIGURE 1-7 Deducing charge states from isotopic envelope pattern. 
Adjacent peaks in an envelope differ by exactly one neutron whose atomic weight is 
roughly 1 amu, hence the spacing size of 1/z, where z is the charge state, on the m/z scale. 
Additionally, the known proportions of naturally occuring heavy isotopes of C, N, and O 
is used to predict the relative abundance of each isotopic species and verify the shape of 
the envelopes. 
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However, when it comes to analyzing crosslinking data, multiple challenges arise 
that hinder both the detection and the identification of crosslinked peptides: 
 Crosslinking reactions are intentionally substoichiometric to prevent over-
crosslinking, resulting in < 1% crosslinked to linear peptide ratios. 
 Crosslinked peptides yield weaker signal in the mass spectrometer due to their 
large average size. 
 Crosslinked peptides generate highly complex MS/MS spectra due to their 
combined large size and high charge states (the number of possible fragmented b- 
and y-ions is directly proportional to combined peptide size and charge state). 
 Fragmentation patterns of crosslinked peptides remain largely unknown. 
 Search space for theoretical crosslinked sequences grows with the square of the 
protein complex size, raising the chance of getting indistinguishable isobaric 
matches and false positives. 
A number of extra functionalities on crosslinking reagents and their accompanying data 
acquisition and analysis strategies were invented over the past decade to alleviate the 
above bottlenecks. Unfortunately, these techniques are not amendable to zero-length 
crosslinkers which add no extra atoms to their crosslinked products. Several reports (68-
69) advocated the use of size exclusion chromatography and strong cation exchange 
chromatography by rationalizing that crosslinked peptides are larger and contain more 
positive charges than their linear counterparts. However, our own analysis suggested that 
there are not enough distinctions in masses and charge states to justify an extra 
fractionation step.  
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The primary goal of this dissertation was to improve the depth-of-coverage and 
confidence of zero-length crosslinks identification by developing a novel multi-tiered MS 
data acquisition and data analysis strategy. Also, a dedicated software tool was developed 
to improve the throughput and eliminate tedious, manual review of complex MS/MS 
spectra. Chapter 2 describes the strategy and software in details, along with their 
validations. 
1.4 Red Blood Cell Membrane Cytoskeleton 
The red blood cell membrane cytoskeleton is responsible for maintaining the 
integrity of and providing elasticity for the biconcave-shaped membrane, maximizing 
surface area for rapid oxygen-carbon dioxide exchange and allowing the cells to squeeze 
through tiny capillaries. The organization structure of the red cell membrane cytoskeleton 
were extensively investigated (70-73) and high-specificity purification techniques for 
isolating its major components were developed, making red cell membrane cytoskeleton 
an ideal, tractable model system for protein structural studies. The fact that cytoskeleton 
proteins undergo large conformational rearrangements in response to environmental 
stresses (74-75) to sustain the membrane also makes this system attractive for 
interrogating the relationship between protein complex structures and functions. 
Furthermore, a number of disease-related mutations on cytoskeletal proteins that disrupt 
red cell membrane structure were well-characterized, providing excellent opportunities to 
translate basic structural biology knowledge into clinically-relevant information. 
The key members of the red cell membrane cytoskeleton include spectrin, ankyrin, 
protein 4.1, and actin with spectrin as the primary component (70-71). Spectrin forms 
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anti-parallel αβ-heterodimers that can undergo head-to-head association and become 
predominantly 1 MDa tetramers and moderately higher-order oligomers which are 
anchored to the cell membrane via actin-protein 4.1 junctional complexes at the ends and 
via ankyrin-Band3 complexes in the middle (FIGURE 1-8). Spectrin consists of 
homologous ~106 amino acids domains, termed spectrin domains, each assuming a three-
helix bundle tertiary structure (FIGURE 1-9) (76). α-spectrin contains 20 full spectrin 
domains, a partial one-third domain at its N-terminal, an SH3 motif, and an EF hand 
domain at its C-terminal. β-spectrin contains 16 complete domains, a partial two-third 
domain at its C-terminal, an ankyrin binding site (77-79), and an actin binding domain at 
its N-terminal. Lateral dimerization of α- and β-spectrin initiates through high affinity 
interaction between α20-21 and β1-2 domains (80-81), and is followed by lower affinity 
association along the protein lengths (82). Spectrin dimers then enter the equilibrium 
between closed dimers where the partial domain α0 folds back and binds to the 
complementary partial domain β17 and complete a three-helix bundle structure, open 
dimers, and tetramers when two open dimers associate head-to-head (83) (FIGURE 1-10). 
A crystal structure for this important binding site (β16-17 and α0-1 domains) was 
determined (84), and also represented one of the larger crystal structures of spectrin 
domains available (FIGURE 1-9). 
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FIGURE 1-8 Red cell membrane cytoskeleton. 
LEFT: Electron microscopy image of the spread erythrocyte membrane cytoskeleton 
showing hexagonal lattice of spectrin tetramer filaments anchored by actin junctional 
complexes at the end-points and ankyrin complexes in the middle. Image taken from (85). 
RIGHT: Schematic of the side view of the membrane cytoskeleton. Image taken from 
(86). 
 
FIGURE 1-9 The three-helix bundle secondary structure and spectrin tetramerization site. 
TOP: All crystal structures of spectrin-type domains consistently show that each domain 
adopt an almost identical three-helix bundle tertiary structure, justifying the use of 
homology modeling with these structures as templates for larger spectrin-type proteins. 
BOTTOM: Crystal structure for the spectrin tetramerization site (PDB: 3LBX). Domains 
are coded from left to right: β16 (blue), β17-α0 (cyan-green), and α1 (yellow). 
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FIGURE 1-10 Spectrin domain structure and dimer-tetramer equilibrium. 
TOP: Spectrin heterodimers consist of laterally associated α- and β-spectrin (yellow and 
cyan, respectively). Each of α- and β-spectrin is comprised primarily of ~106 residue 
homologous domains. Other domains include ABD – Actin Binding Domain, and EF – 
EF hand domain. BOTTOM: Spectrin closed dimer-open dimer-tetramer equilibrium. 
  
Spectrin tetramers possess extreme elasticity which is a major source of 
deformability of the red cell membrane, as they are able to transform between an 
approximate 700 Å conformation at physiological condition (87-89) and an extended 
2000 Å structure under tensile stress or low ionic strength media (88, 90). Spectrin’s 
ability to dynamically interconvert between dimer, tetramer, and higher oligomer states is 
also believed to provide a considerable contribution to the maintenance of membrane 
integrity (91). To shed light on the structural and functional properties of spectrin, mini-
spectrin (92) (FIGURE 1-11), a 90 kDa recombinant protein containing the spectrin 
tetramer interface that closely mimics spectrin closed dimer-open dimer-tetramer 
equilibrium, was developed in our laboratory. Mini-spectrin consists of an equivalent of 
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seven full spectrin domains with the addition of a flexible 16-residue glycine linker to 
stabilize lateral αβ association. A preliminary medium-resolution homology model for the 
180 kDa mini-spectrin tetramer was previously developed in our laboratory (49). 
However, it was supported by only a few crosslinks based on small manually-analyzed 
zero-length crosslinking datasets. In order to generate final, experimentally-verified 
medium-resolution structures for mini-spectrin dimer and tetramer, in this dissertation, 
we utilized our improved zero-length crosslinking strategy in conjunction with homology 
modeling. Chapter 3 describes zero-length crosslinking and homology modeling of mini-
spectrin. 
 
FIGURE 1-11 Schematic of mini-spectrin. 
TOP: Mini-spectrin consists of 16 domains surrounding the spectrin tetramer binding site. 
BOTTOM: Mini-spectrin closely mimics the spectrin dimer-tetramer equilibrium. 
  
Hereditary elliptocytosis (HE) mutations weaken the erythrocyte membrane 
cytoskeleton, resulting in deformed elliptical-shaped red blood cells and hemolytic 
anemia in severe cases (93). It is estimated that roughly 1 in 2,000 to 4,000 individuals in 
the United States has some forms of HE (93). HE-related defects have been mapped to a 
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large number of genetic loci in α-spectrin, β-spectrin and, to a much lesser extent, other 
membrane cytoskeleton components, and were found to involve all level of genetic 
alteration from point mutations to gene insertions and deletions (93-94). While the 
majority of the known mutations are located in the immediate vicinity of the spectrin 
tetramer binding site (94), distal mutations such as αL207P and αL260P (95-96) are 
located more than 100 Å away from the tetramerization site. These distal mutations 
appear to affect the tetramer formation through unknown mechanisms (FIGURE 1-12). In 
Chapter 4, we describe structural characterization of mini-spectrins containing these two 
HE-related mutations using chemical crosslinking, homology modeling, and several 
supporting biophysical experiments. As a result, an experimentally-verified medium-
resolution structure for αL207P closed dimer satisfying a number of mutant-specific 
crosslink-derived distance constraints was successfully developed. Subsequent 
comparative analysis between the mutant and the wild-type dimer structures illustrates 
the utility of zero-length crosslinking in probing large, dynamic conformational 
rearrangements. Overall, our data provided insights into the mechanisms of how these 
distal HE-related mutations alter the balance of the spectrin dimer-tetramer equilibrium, 
consequently destabilizing the red cell membrane cytoskeleton and the membrane itself. 
 
FIGURE 1-12 Locations of some common “distal” HE-related mutation sites.  
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Chapter 2: Identification of Zero-Length Crosslinks in 
Proteins using Label-Free Quantitation and High-
Resolution Fragment Ion Spectra 
 In this chapter, we describe our multi-tiered strategy for identifying zero-length 
crosslinks. The method utilizes two prevalent proteomics techniques – namely label-free 
quantification and targeted tandem mass spectrometry – along with a new software tool, 
ZXMiner. Small proteins with known crystal structures – glutathione S-transferase (GST, 
25 kDa) and myoglobin (19 kDa) – were used to validate the pipeline and to optimize 
computational analysis parameters. The performance of ZXMiner was then compared to 
major existing crosslink analysis software using the GST dataset. Furthermore, to 
illustrate the feasibility of our current method on large protein complexes, crosslinking of 
the 526 kDa spectrin heterodimers, the isolated membrane cytoskeleton (> 1 MDa), and 
the intact red cell membrane (> 2 MDa) were performed. Notably, these experiments 
represent the largest zero-length crosslinking datasets analyzed to date. 
2.1 Introduction 
Chemical crosslinking coupled with mass spectrometry (CX-MS) is a valuable 
tool for probing protein complexes that complements protein biophysical methods and 
high-resolution structural determinations, as it provides distance constraints between 
specific protein residues. Particular advantages are that CX-MS can be applied to 
heterogeneous protein mixtures and very large protein complexes where high-resolution 
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techniques such as X-ray crystallography and NMR cannot be directly exploited.  
Similarly, structural information can be obtained from flexible or disordered proteins or 
physiologically-important conformational changes on proteins that are too large for NMR.  
Determining proximity for specific amino acid side chains can identify or confirm 
protein-protein interactions or support structural model predictions by both distinguishing 
between alternative predicted models and providing distance constraints for further model 
refinement. 
 CX-MS emerged as an important experimental tool in the late 1990s (26-27) and 
has been applied to diverse biological problems (30-33, 97). The extensive progress in 
this field over the past decade has been recently reviewed (20-24, 98-99).  Historically, 
the biggest challenge in crosslink experiments has been identification of crosslink 
products, which are usually present at very low stoichiometry, often produce weak MS 
signals, and yield complex MS/MS spectra. The availability of high-resolution MS for 
analysis of proteolyzed crosslinked proteins or complexes has been a key advance in the 
field (100). Progress has been further facilitated by development of a substantial number 
of crosslink reagents that facilitate MS identification of crosslinked products (22), 
including incorporation of isotopic labels (101), MS-labile bonds (35-36), and enrichment 
tags (37, 102). In addition, a number of software tools have been developed to take 
advantage of the unique MS and MS/MS signatures produced by these specialized 
crosslinkers. However, the main drawback of crosslinkers that utilize these MS-friendly 
properties is that the spacer arm length is usually substantial. This greatly reduces the 
stringency, and therefore the value, of the resulting distance constraints (21). Bifunctional 
crosslinkers also give rise to dead-end and self-loop products (38) – linear peptides 
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connected to only one end or both ends of the crosslinker reagent. The presence of 
products from these side reactions further increases the complexity of peptide mixtures 
and data analysis. 
 In contrast, “zero-length” crosslinkers such as EDC, eliminate a water molecule 
when a bond is formed between an amine and a carboxyl group, rather than adding any 
extra atoms to the crosslinked products.  Hence, they yield the most stringent distance 
constrains, which are optimal for identifying contact sites in multi-protein complexes and 
for aiding computational molecular modeling (21). Another advantage of zero-length 
crosslinkers is that they generally do not form stable dead-end and self-loop crosslinked 
products.  But, the lack of a spacer arm does not allow incorporation of isotope labels or 
affinity tags, and relatively few studies have utilized zero-length crosslinkers with the 
majority of systems studied having less than 100 kDa of unique protein sequence (48, 51, 
53, 56, 58, 60).  The unique protein sequence size is the most appropriate measure of data 
analysis complexity in a crosslink experiment as complexity scales with the number of 
unique peptides and not the actual complex size.  That is, a 400 kDa heterodimer is a far 
more challenging problem that a 400 kDa complex comprised of 10 copies of a 40 kDa 
polypeptide chain.  
 The most important factor that has restricted the use of zero-length crosslinkers to 
relatively small protein sequence-sized problems is the paucity of robust software tools 
that have been optimized for zero-length crosslink data.  As a result, many prior studies 
involving zero-length crosslinks required extensive manual data analysis, which is 
undesirable because it is subjective and tedious.  Most existing software tools were either 
developed specifically for non-zero-length crosslinkers or optimized based on non-zero-
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length crosslink datasets, and the few that are capable of processing zero-length crosslink 
datasets do so with critical limitations (39). Also, most existing software tools do not 
consider the important fact that a zero-length crosslink between adjacent peptides will 
have an identical precursor mass to an incomplete proteolysis of these adjacent peptides, 
and the MS/MS spectra are often quite similar.  Another issue that is often not fully 
considered when interpreting datasets from crosslink experiments is that very low false 
discovery rates are essential and maximum depth of analysis is highly desirable.  
Accurate crosslink assignment is critical because even a single false positive 
identification can be quite detrimental, leading to incorrect assignments of protein-protein 
interactions or incorrect distance constraints for molecular modeling that will result in 
inaccurate structures.  At the same time, failure to assign a significant portion of the 
actual crosslinks present in a simple will usually diminish the value of the dataset due to 
missed distance constraints.  Hence, a dedicated analytical strategy and software tools 
that are optimized for zero-length crosslinking is needed to fully realize the potential 
offered by these more precise distance constraints. 
In this study, we developed software and an analytical strategy that was optimized 
for highly accurate identification of zero-length crosslinks.  The analytical method 
integrated two common proteomics techniques – namely label-free quantitation and 
targeted mass spectrometry – into a multi-tiered strategy yielding high-resolution MS/MS 
data with high depth-of-analysis for crosslinked peptides. An accompanying software 
tool, Zero length Crosslink Miner (ZXMiner), facilitates data acquisition processes and 
provides an optimized computational analysis of high-resolution MS/MS data in zero-
length crosslink datasets. The data acquisition and analysis strategy was validated on 
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proteins with known crystal structures.  The performance of ZXMiner compared 
favorably with alternative software tools currently used for crosslinked peptide analysis.  
We demonstrate that good depth of analysis can be achieved with false discovery rates 
(FDR) of less than 1%.  Importantly, this new method is not significantly limited by size 
of protein complex as even intact cell membranes can now be probed by zero-length 
crosslinking. 
2.2 Results 
2.2.1 Development and Optimization of the Multi-Tiered MS Analysis for Zero-
Length Crosslinks 
An overview of the multi-tiered LC-MS/MS data acquisition strategy and 
associated software for analysis of zero length crosslinks is summarized in FIGURE 2-1. 
This approach involves: 1) label-free comparison of crosslinked and control samples, 2) 
matching of theoretical crosslinked peptides to putative crosslinks using low-resolution 
MS/MS data, 3) targeted mass spectrometry to acquire high-resolution MS/MS data on 
potential crosslinks, and 4) automated identification of crosslinked peptides.  Individual 
steps in the procedure were optimized primarily using standard proteins with known 
crystal structures with further testing on larger protein complexes.  Because zero-length 
crosslinking does not allow incorporation of isotope tags or affinity tags to aid in 
identification of crosslinked peptides, we found that label-free comparison of high-
resolution LC-MS data was the most effective method for filtering out many non-
crosslinked precursors. For each protein or protein complex of interest, LC-MS data for 
an untreated control sample were aligned against data from all crosslinking reactions for 
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that protein (typically multiple reaction times and temperatures). Any precursor signals at 
least 10-fold enriched in at least one of the crosslink samples compared to the untreated 
control were designated as crosslink candidates. Ideally, all crosslinked peptides would 
produce signals that are unique to the crosslinked reactions and completely absent in the 
control. But in complex samples, unrelated signals will frequently randomly overlap one 
or more peaks in the isotopic envelope, giving a non-zero intensity background level in 
the control (FIGURE 2-2). For simplicity, peptide ions either unique to the crosslinked 
samples or enriched by at least 10-fold based on the label-free comparison will be 
referred to below as “enriched” signals or candidate crosslinks. 
The list of candidate crosslinked peptides from the label-free comparison is 
subsequently narrowed down by comparing precursor masses enriched in the crosslinked 
samples to those of theoretical crosslinks of peptides from the protein(s) analyzed.  The 
utility of this step is dependent upon the size of the protein or protein complex being 
analyzed because the number of theoretical crosslinks increases with the square of the 
amount of unique protein sequence, resulting in more random matches between observed 
and theoretical precursor masses. For GST (26 kDa unique sequence; 52 kDa 
homodimer), about 10% of the enriched signals matched a theoretical crosslink, but for 
large protein complexes like red cell spectrin heterodimers (526 kDa unique sequence) 
more than half of  
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FIGURE 2-1 Multi-tiered data acquisition and analysis pipeline for zero-length crosslinks.  
Steps highlighted in gold boxes are performed automatically in ZXMiner. 
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FIGURE 2-2 Imperfect label-free comparison. 
(A) Label-free comparison between crosslink and control samples greatly narrow down 
the list of candidate precursor masses. Only signals enriched in crosslink samples are 
retained for downstream analysis. (B) Weak unrelated MS signals from the control (red 
peak profile, indicated by the arrows) will sometimes overlap crosslinked peptide 
precursors by random chance in complex mixtures. Therefore a 10-fold enrichment 
threshold rather than only crosslink-specific signals needs to be considered. 
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the enriched signals matched a theoretical crosslink. Furthermore, while each enriched 
signal from GST usually matched a single theoretical crosslink, enriched signals from 
spectrin heterodimer matched an average of about 30, and as many as 50 distinct 
theoretical crosslinks.  This rapid increase in complexity, even when label-free 
comparisons were used, illustrated the need for improved data acquisition and data 
analysis tools. 
Even when moderate-sized proteins were analyzed and a stringent 5 ppm 
precursor mass tolerance was applied, most matches between enriched precursor signals 
and theoretical crosslinks occurred by chance. Less than 5% of these initial matches were 
subsequently identified as true crosslinks, illustrating further refinement of the candidate 
crosslinked peptide list was needed.  As the initial discovery LC-MS/MS analysis also 
produced low-resolution MS/MS spectra, these data were further evaluated by 
comparison to the expected fragment spectra of theoretical crosslinked peptides to further 
distinguish the best candidate crosslinks. Three fundamental scoring functions were used 
to evaluate the quality of such comparisons, including: Peak Coverage, Intensity 
Coverage, and Ion Coverage (see Experimental Procedures). The geometric mean of 
these three scores (GM score) was used to rank crosslink identifications. Based upon 
initial tests, a preliminary GM score threshold for filtering low-resolution MS/MS spectra 
was set at 0.4 to ensure high crosslink coverage. Lastly, to ensure that every candidate 
crosslink would be targeted at least once in the subsequent high-resolution LC-MS/MS 
runs, no more than 80-100 precursors were generally assigned to each 85-min run. To 
ensure comprehensive detection of crosslinks in initial evaluations, four targeted LC-
MS/MS runs were used for GST and one targeted run for myoglobin sample.  However, 
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subsequent analyses showed that the number of targeted runs could be reduced with 
minimal impact on depth of analysis.  Another effective way of reducing the number of 
required runs and required crosslinked sample was to use a longer gradient so that more 
targeted MS/MS acquisitions could be fit into a single run.  For example, a 4-hr LC 
gradient could easily accommodate 300-400 targeted precursors per LC-MS/MS run on 
an Orbitrap XL instrument, and only two targeted 4-hr runs were required for each 
spectrin heterodimer sample to analyze all candidates (see below).  Also, newer, faster 
instruments should be able to accommodate even more targeted precursors per run. 
2.2.2 Analysis of GST and Myoglobin 
To evaluate our strategy and refine scoring schemes, chemical crosslinking 
experiments using EDC/sulfo-NHS were performed on GST and myoglobin, whose 
crystal structures are available (PDB: 1GTA and 1YMB, respectively). Using high-
resolution targeted LC-MS/MS data, each putative crosslink was annotated as a true 
crosslink or non-crosslink based on alpha Carbon-alpha Carbon (Cα-Cα) distances in the 
pertinent crystal structure and review of MS/MS spectra annotations.  Also, the influence 
of mobile regions in the crystal structures (higher b-factors) and involvement of likely 
flexible regions of the molecule such as loops, subunit interfaces, and the protein termini 
on crosslinkable residue distances were examined. Based on an typically accepted Cα-Cα 
distance limit of 12 Å for zero-length crosslinks (103), crosslinks occurring between 
residues whose alpha Carbons are at most 12 Å apart, and where good matches between 
observed and theoretical spectra occurred, were labeled as true positive crosslinks.  To 
further verify these assignments, the fit between expected and observed fragment ions 
was manually inspected. This 12 Å Cα-Cα distance limit corresponds roughly to the sum 
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of fully-extended lengths of the side chains of lysine and glutamate or aspartate (K ≈ 6.3 
Å, E ≈ 3.8 Å, and D ≈ 2.5 Å) plus an additional 2 Å that might be contributed by 
uncertainty due to molecular dynamics in solution, or crystal structure resolution, or both.  
Crosslinks whose Cα-Cα distances exceeded 20 Å were automatically labeled as non-
crosslinks, as the high level of molecular flexibility in solution needed to account for 
such events seemed unlikely to yield resolvable structures in crystallographic analyses.  
Cα-Cα distances between 12 and 20 that involved residues located in regions likely to be 
flexible were tentatively considered true positives. By visual inspection of the structure, 
each crosslink was also required to occur between residues with a clear path between the 
two side chains to qualify as a true positive crosslink, and as noted above, MS/MS 
spectra were carefully scrutinized to confirm the assignment as a positive crosslink. 
With less than 1% FDR (GM score > 0.38), we identified 25 crosslinked peptides 
(counting different methionine oxidation states and charge states) in the GST sample 
(TABLE 2-1), all of which were confirmed to be true positives by the annotation and 
spectral review criteria described above. These crosslinks correspond to 13 unique 
sequences and 10 distinct crosslinked sites on the molecule (FIGURE 2-3A). The fact that 
most of the crosslinks were observed at multiple charge states and/or oxidation states of 
methionine further supports the reported crosslink assignments.  Complete annotation of 
the GST datasets also revealed that the GM score derived from high-resolution MS/MS 
data is a powerful indicator of true crosslinks (FIGURE 2-3B) that is far superior to scores 
from low-resolution data (FIGURE 2-3C).  Specifically, the area under the curve for the 
corresponding ROC curve is 0.99 for GM score derived from high-resolution data and as 
high as 80% sensitivity can be achieved without any false positives (FIGURE 2-3C). 
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Furthermore, all of the true crosslinks with intermediate GM scores (0.2 to 0.4) were also 
detected at other charge states or with different methionine modification state where the 
GM score was higher than 0.4 (FIGURE 2-3B). For the myoglobin dataset, ZXMiner 
identified 15 true positive crosslinks corresponding to 7 unique sequences and 6 different 
crosslinked sites (FIGURE 2-4A, TABLE 2-1). The GM score derived from high-resolution 
MS/MS data also performed very well on this dataset (FIGURE 2-4B, C) with a perfect 
area under the ROC curve of 1.00. 
2.2.3 Impact of High-Resolution MS/MS Data 
One major limitation of low-resolution MS/MS data that is particularly a problem 
for both manual and automated crosslinked peptide assignments is the fact that it is 
impossible to confidently identify isotopic envelopes and charge states.  Most crosslinked 
peptides have charge states of at least +3 and many are +4 or +5 (TABLE 2-1), and 
therefore MS/MS spectra of crosslinked peptides generally contain b- and y-ions with 
multiple charge states or at least multiple possible charge states. For example, 
fragmentation of the +5 precursor ion of a crosslinked peptide can produce b- and y-ions 
that are +1, +2, +3, or +4. In low-resolution spectra, the combined uncertainty of charge 
state and low mass accuracy for each ion (about ±0.5 amu) results in numerous random 
matches between observed and expected fragment ions. High-resolution data acquisition 
greatly reduces ambiguity in the MS/MS spectra by both reducing mass error from 0.5 amu to 
low ppm levels and allowing isotopic envelopes to be resolved with accurate determination of 
charge state and monoisotopic m/z for the majority of the peaks (FIGURE 2-6A). 
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Unique 
Sequence 
ID 
Charge MH+ Crosslink Sequence 
Cα-Cα 
Distance 
GST 
  
1 3,4 2455.2460 YEEHLY[E]R-{MSPILGYW[K]IK 5.5 
1# 5 2471.2400 YEEHLY[E]R-{M#SPILGYW[K]IK 5.5 
2 4 3508.7050 FELGLEFPNLPYYIDG[D]VK-HNMLGGCP[K]ER 8.7 
2# 3 3524.6970 FELGLEFPNLPYYIDG[D]VK-HNM#LGGCP[K]ER 8.7 
3 4 3878.9360 HNMLGGCP[K]ER-NKKFELGLEFPNLPYYIDG[D]VK 8.7 
3# 4 3894.9140 HNM#LGGCP[K]ER-NKKFELGLEFPNLPYYIDG[D]VK 8.7 
4 3,4 3636.7980 KFELGLEFPNLPYYIDG[D]VK-HNMLGGCP[K]ER 8.7 
4# 3,4 3652.7920 KFELGLEFPNLPYYIDG[D]VK-HNM#LGGCP[K]ER 8.7 
5 3,4 2561.4420 LLL[E]YLEEK-IEAIPQID[K]YLK 9.2 
6 4 2717.5410 LLL[E]YLEEK-RIEAIPQID[K]YLK 9.2 
7 3 2734.3930 LLLEYLE[E]K-YIAD[K]HNMLGGCPK 11.4 
7# 3,4 2750.3840 LLLEYLE[E]K-YIAD[K]HNM#LGGCPK 11.4 
8 3,4 2048.0540 [D]F[E]TLK-IAYS[K]DFETLK 11.6 
9 5 3318.7510 YIAWPLQGWQATFGGG[D]HPPK-I[K]GLVQPTR 11.8 
10 4 1856.0400 LLL[E]YLEEK-YL[K]SSK 12.4 
11 3 3068.6050 LP[E]MLK-[K]FELGLEFPNLPYYIDGDVK 12.4 
11# 3 3084.6010 LP[E]M#LK-[K]FELGLEFPNLPYYIDGDVK 12.4 
12 3 3726.9063 YIAWPLQGWQATFGGGDHPP[K]}-V[D]FLSKLPEMLK 14.6* 
13 3 3035.4860 MFE[D]R-[K]FELGLEFPNLPYYIDGDVK 15.8* 
 
   
Myoglobin 
  
1 4,5 1925.068 LFTGHPETL[E]K-F[K]HLK 6.00 
2 4 1327.690 ASE[D]LK-FD[K]FK 8.10 
3 4 3778.946 {GLS[D]GEWQQVLNVWGK-[K]GHHEAELKPLAQSHATK 8.50 
4 4,5 2339.208 LFTGHPETL[E]K-HL[K]TEAEMK 10.90 
4# 3,4 2355.202 LFTGHPETL[E]K-HL[K]TEAEM#K 10.90 
5 3,4,5 2757.448 NDIAA[K]YK-GHH[E]AELKPLAQSHATK 11.80 
6 4,5 2885.542 NDIAA[K]YK-KGHH[E]AELKPLAQSHATK 11.80 
7 3,5 3094.781 V[E]ADIAGHGQEVLIR-HGTVVLTALGGIL[K]K 12.20 
 
TABLE 2-1 GST and myoglobin crosslinks identified at FDR of less than 1%. 
Asterisks indicate crosslinks involving flexible regions whose Cα-Cα distances 
significantly exceed 12 Å. # indicates oxidized Methionine (+15.99492). All Cysteines 
are carboxyamidomethylated (+57.02146). { } indicates the protein N- and C-terminus, 
respectively. [ ] indicates crosslinked sites. 
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FIGURE 2-3 Crosslink analysis using GST. 
(A) Locations of identified crosslinks on the crystal structure of GST homodimer (PDB: 
1GTA). Lys residues are highlighted in blue and Glu and Asp are in red. Black lines 
connect the two alpha Carbons of each crosslink. Crosslinks between residues whose Cα-
Cα distances are significantly larger than 12 Å were highlighted in orange. (B) Scatter 
plot showing the relationship between GM scores derived from high-resolution MS/MS 
data and Cα-Cα distances for all crosslink candidates in the GST dataset. A few 
crosslinks located in regions likely to exhibit increased flexibility such as loops or inter-
subunit interfaces exceeded the expected 12 Å maximum Cα-Cα distance. (C) ROC 
curves showing the superior performance of high-resolution MS/MS data (area under the 
curve = 0.99) compared to low-resolution data (area under the curve = 0.80). 
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FIGURE 2-4 Crosslink analysis using myoglobin. 
(A) Locations of identified crosslinks on the crystal structure of myoglobin monomer 
(PDB: 1YMB). Lys residues are highlighted in blue and Glu and Asp are in red. Black 
lines connect the two alpha Carbons of each crosslink. (B) Scatter plot showing the 
relationship between GM scores derived from high-resolution MS/MS data and Cα-Cα 
distances for all crosslink candidates in the GST dataset. (C) ROC curves showing the 
perfect performance (area under the curve = 1.00) of high-resolution GM score in this 
dataset 
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We considered discarding all peaks with unidentifiable charge states from the analysis to 
further reduce uncertainty, but results were very similar to those obtained when ions with 
unassigned charge states were retained (FIGURE 2-5). Importantly, the GM scores of 
most non-crosslinks were reduced to zero when high-resolution MS/MS spectra was 
evaluated, indicating that the majority of the matches between observed and theoretical 
ions in the low-resolution scans occurred by random chance for these non-crosslinked 
peptides (FIGURE 2-6B). 
2.2.4 Comparison to StavroX, Crux, pLink, and MassMatrix 
To evaluate the performance of our software developed specifically for zero-
length crosslink datasets, we compared ZXMiner to several common existing crosslink 
analysis programs, namely StavroX (104), Crux (105-106), pLink (43), and MassMatrix 
(41-42). StarvoX was considered because it had been shown to outperform a number of 
other software packages. Crux was chosen since it best represents the concept of adapting 
well-established database search algorithms for crosslinking, as it improved upon 
prominent alternatives. Furthermore, Crux was developed based on zero-length crosslink 
datasets with EDC. pLink was included due to its unique capability to utilize ppm-level 
fragment mass tolerance and hence it is most suitable for high-resolution MS/MS data. 
Lastly, MassMatrix was pertinent because it was utilized in several recent studies that 
utilized zero-length crosslinking (53, 56, 60).  One important special situation when 
considering zero-length crosslinks is possible crosslinks between adjacent tryptic 
peptides vs. an incomplete cleavage, as both will have identical precursor masses. 
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FIGURE 2-5 Effect of removing MS/MS peaks with unassigned charge states. 
Using high-resolution MS/MS information, we can de-isotope the majority of the peaks 
to determine their charge states and monoisotopic masses. The remaining peaks can either 
be removed from further analysis since they are ambiguous and could result in erroneous 
matches or be retained and allowed to assume all possible charge state assignments. The 
two alternative strategies were compared using the GST dataset and only minor 
differences in crosslink identification performance were observed. Scatter plots show the 
scores of positive and negative crosslinks (A) using all MS/MS peaks or (B) using only 
peaks with assigned charge states. The corresponding areas under the ROC curve are 
0.9931 and 0.9934, respectively. 
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FIGURE 2-6 Impact of high-resolution MS/MS spectra. 
(A) At high-resolution, isotopic envelopes, monoisotopic m/z, and charge states can be 
determined for the majority of the MS/MS peaks. The bottom panels zoom in on a small 
m/z window to highlight how de-isotoping greatly reduces the complexity and ambiguity 
of the spectrum. (B) Bar plots illustrating the improved discriminatory power of GM 
scores obtained from high-resolution MS/MS data (right panel) compared to those based 
on low-resolution data (left panel). The plot for low-resolution data was truncated 
because only crosslink candidates with low-resolution GM score of at least 0.4 were 
further analyzed. 
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Because there is generally not enough MS/MS evidence to reliably distinguish between 
these two cases, we expected that including these “adjacent-peptide crosslink” 
identifications will result in high false positive rates. Furthermore, it is important to note 
that many true adjacent-peptide crosslinks will involve proximal residue positions that 
will provide less crucial structural information. In fact, examination of 11 adjacent-
peptide crosslinks collectively reported by StavroX and Crux (TABLE 2-2) revealed that 
two of them are false positives (Cα-Cα distances > 26.7 Å) and seven others occur 
between nearby residues on the protein sequence and in the crystal structure and are 
therefore uninformative. Hence, all such crosslinks were excluded for the following 
comparisons of different programs in order to be consistent across software packages. 
Exact crosslinked site information within an identified crosslinked complex was not 
considered here because some programs either do not automatically assign crosslink sites 
or do not rank the relative fit of alternative linkages.   
 GST crosslink datasets were used to compare the performance of ZXMiner 
against existing crosslinking analysis software tools. Raw files containing low-resolution 
MS/MS data were input into Crux (105-106), StavroX (104), and MassMatrix (41-42). 
High-resolution MS/MS runs of the same crosslinked sample were used for pLink (43) as 
this is the only program other than ZXMiner that can utilize high resolution MS/MS data. 
Raw file format conversions were performed using ProteoWizard v3.0.4472 (107). FDRs 
were set to be within 5% in all programs for consistency because this level is 
automatically set in some programs and cannot be adjusted. Overall, a total of 15 unique 
true crosslink sequences were identified (TABLE 2-3) and 8 of them were reported by at 
least four software tools. However, variations across programs were much greater at the 
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Peptide A Peptide B 
Cα-Cα Distance 
Intra         Inter 
LLLEYLEEKYEEHLY[E]R DEGD[K]WR x 49.8 
YEEHLY[E]R DEGD[K]WR x 49.8 
DEG[D]K WRN[K]K x 52 
DEG[D]KWR N[K]K x 52 
N[K]K F[E]LGLEFPNLPYYIDGDVK x 52.3 
RIEAIPQI[D]K YL[K]SSK x 58.1 
IEAIPQI[D]K YL[K]SSK x 58.1 
I[K]GLVQPTR LLL[E]YLEEK 13.6 40.3 
IAYS[K]DFETLK V[D]FLSK 14.5 15.6 
LLL[E]YLEEK YEEHLYERDEGD[K]WR 26.7 45.5 
LLLEYLEE[K]YEEHLYER [D]EGDK 27.5 54.5 
 
TABLE 2-2 Crosslinks involving adjacent peptides on GST. 
Eleven crosslinks were reported collectively by StavroX and Crux involving adjacent 
tryptic peptides. Since GST forms homodimers, both intra-subunit and inter-subunit 
interpretations were considered for each crosslink. X’s indicate that the crosslinked sites 
occur within 3-6 residues and so the associated Cα-Cα distance will be within 12 Å for 
most conformations. These interpretations therefore will usually not contribute useful 
distance constraints, even if they are true. Overall, two putative crosslinks are clearly 
false positives and most others are uninformative or false positives. 
 
unique precursor level where charge states and methionine oxidation states are 
considered as different, as out of 43 true positive crosslinks, 16 were uniquely identified 
by a single software tool and 12 were reported by only two programs (FIGURE 2-7). 
Using an FDR of <5%, ZXMiner provided the highest number of identifications at the 
unique precursor level with 30 positive crosslinks, followed by StavroX (20 crosslinks), 
Crux (19 crosslinks), and MassMatrix (15 crosslinks), while pLink yielded only 6 
crosslinks.  Interestingly, when the FDR for each dataset was recalculated based upon the 
actual observed true positive crosslinks, the precursor level FDR was much higher than 
41 
 
that estimated by the other programs with FDRs ranging from 21 to 33%, whereas the 
actual FDR for ZXMiner increased moderately to 6.3% (TABLE 2-3).  Furthermore, when 
the FDR at the unique sequence level rather than unique precursor level was considered, 
all programs, including ZXMiner, showed an unacceptably high actual FDR when an 
input FDR of <5% was used.  Because all of these FDRs were unacceptably high, 
ZXMiner was also run using an FDR of <1%.  Importantly, at this level, no false 
positives assignments were made, and while the number of identifications at the unique 
sequence level decreased from 15 to 13, this is an acceptable moderate reduction in depth 
of analysis considering that false positive assignments were eliminated (TABLE 2-3) 
 In addition to high FDRs, StavroX, Crux, and MassMatrix had other significant 
limitations when analyzing zero-length crosslink datasets that may have contributed to 
their poor performance in this comparison. For example, MassMatrix only considers 
crosslinks between a single pair of residues, which meant that for EDC crosslinks, two 
separate runs were needed for Lys-Glu and Lys-Asp and crosslinks involving protein 
termini were not considered. On the other hand, Crux could not search for crosslinked 
peptides with variable modifications and the fragment mass tolerance cannot be specified. 
Lastly, StavroX reported a number of crosslinks that involved a lysine residue as one of 
the crosslinked sites that was at the C-terminal end of a tryptic peptide – a situation that 
should not occur since crosslinked lysine residues should not be cleaved by trypsin. 
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Unique 
Sequence 
ID 
Peptide Sequence 
Cα-Cα 
Distance 
ZXMiner pLink StavroX Cruxa 
Mass 
Matrixb 
True Positives 
       
1 YEEHLYER-{MSPILGYWKIK 5.5 3,4 3,4,5 3 3,4,5 3,4 5 
1# YEEHLYER-{M#SPILGYWKIK 5.5 5 4,5 - 3,4 N/A 5 
2 
FELGLEFPNLPYYIDGDVK-
HNMLGGCPKER 
8.7 4 4 - - 3,4 4 
2# 
FELGLEFPNLPYYIDGDVK-
HNM#LGGCPKER 
8.7 3 3 - - N/A 3 
3 
HNMLGGCPKER-
NKKFELGLEFPNLPYYIDGDVK 
8.7 4 4,5 - - 4,5 4 
3# 
HNM#LGGCPKER-
NKKFELGLEFPNLPYYIDGDVK 
8.7 4 4 - - N/A 5 
4 
KFELGLEFPNLPYYIDGDVK-
HNMLGGCPKER 
8.7 3,4 3,4 - - 3,4 3 
4# 
KFELGLEFPNLPYYIDGDVK-
HNM#LGGCPKER 
8.7 3,4 3,4 - - N/A 5 
5 LLLEYLEEK-IEAIPQIDKYLK 9.2 3,4 3,4 3 3,4 3,4 - 
6 LLLEYLEEK-RIEAIPQIDKYLK 9.2 4 4 - 4 - - 
7 YEEHLYER-{M#SPILGYWK 10.0 - - - 3,4 N/A N/A 
8 LLLEYLEEK-YIADKHNMLGGCPK 11.4 3 3 3 - 3 3 
8# LLLEYLEEK-YIADKHNM#LGGCPK 11.4 3,4 3,4 - - N/A - 
9 DFETLK-IAYSKDFETLK 11.6 3,4 3,4 3 3 3,4 - 
10 
YIAWPLQGWQATFGGGDHPPK}-
IKGLVQPTR 
11.8 5 5 - 5 5 5 
11 
LPEMLK-
KFELGLEFPNLPYYIDGDVK 
12.4 3 3,4 - 3,4 3,4 3 
11# 
LPEM#LK-
KFELGLEFPNLPYYIDGDVK 
12.4 3 3 - 4 N/A 4 
12 LLLEYLEEK-YLKSSK 12.4 4 4 - 3,4 4 - 
13 
AEISMLEGAVLDIRYGVSR-
YIADKHNM#LGGCPK 
13.8c - - - - N/A 4 
14 
YIAWPLQGWQATFGGGDHPPK}-
VDFLSKLPEMLK 
14.6d - 5 5 - 4,5 5 
14# 
YIAWPLQGWQATFGGGDHPPK}-
VDFLSKLPEM#LK 
14.6d 3 3 - 3,4 N/A 5 
15 MFEDR-KFELGLEFPNLPYYIDGDVK 15.8c,d 3 3 3 - - - 
15# 
M#FEDR-
KFELGLEFPNLPYYIDGDVK 
15.8c,d - - - 3 N/A 3 
 
False Positives        
1 LLLEYLEEK-LVCFKK 16.3 - - - - 3 - 
2 IKGLVQPTR-DEGDK 16.4 - - 3 4 3 - 
3 IKGLVQPTR-DEGDKWR 16.4 - - - 3 - - 
4 DEGDKWR-LPEMLK 18.5 - - - 3,4 3 - 
5 DEGDKWRNK-LPEMLKMFEDR 18.5 - - - - 3 - 
6 VDFLSKLPEMLKMFEDR-ER 19.0 - - - - - 3 
6# VDFLSKLPEMLKM#FEDR-ER 19.0 - - - 3 N/A - 
7 IKGLVQPTR-LLLEYLEEK 19.1 - - - - - 3 
8 
{MSPILGYWKIK-
ERAEISMLEGAVLDIR 
20.9 - - - 4 - - 
9 ERAEISMLEGAVLDIRYGVSR- 21.5 - - - - 3 - 
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WRNKK 
10 IKGLVQPTR-DFETLK 22.7 - 3 3 - 3 3 
11 HNMLGGCPKER-LVCFKK 23.9 - - - - 3 - 
12 LLLEYLEEK-DEGDKWR 25.2 - 3 - 3 - - 
13 
YEEHLYERDEGDKWR-
AEISM#LEGAVLDIR 
27.2 - - - - N/A 4 
14 
VDFLSKLPEMLKMFEDR-
YIADKHNMLGGCPK 
28.5 - - - - 5 - 
15 IEAIPQIDKYLK-MFEDR 29.6 - - 3 - - - 
16 LLLEYLEEK-LPEMLKMFEDRLCHK 33.4 - - - - 3 - 
17 DFETLK-LVCFKK 34.2 - - - 3 - - 
 Estimated FDR: < 1% < 5% < 5% < 5% < 5% N/A 
Unique Precursor Level 
True Positives: 25 30 6 20 19 15 
False Positives: 0 2 3 8 9 4 
Actual FDR: 0% 6.3% 33% 29% 32% 21% 
Unique Sequence Level 
True Positives: 13 15 6 10 11 10 
False Positives: 0 2 3 7 9 4 
Actual FDR: 0% 12% 33% 41% 45% 29% 
 
TABLE 2-3 Comparison of GST crosslink identifications using alternative software. 
For each peptide sequence, charge states of the crosslink identified by each software 
package are indicated. Estimated FDRs were derived from the decoy data that each 
software package provided (not available from MassMatrix). Number of identifications, 
false positives, and the actual FDRs were calculated directly from this table. 
a
 Crux 
cannot identify peptides with variable modifications. 
b
 MassMatrix cannot identify 
crosslinks involving the protein terminus as one of the crosslinked sites. 
c 
Crosslinks 
between subunits. 
d
 Crosslinks involving flexible regions (as reflected by the elevated B-
factors and/or loops). 
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FIGURE 2-7 Consistency of crosslink identification across software packages. 
The histogram shows the number of true crosslinked peptides that were reported by one, 
two, three, four, or all software packages. At the unique precursor level, crosslinks with 
distinct charge states or methionine oxidation states were counted as separate entries. At 
the unique sequence level, only differences in amino acid sequences were counted.  
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2.2.5 Feasibility of using zero-length crosslinking on 526 kDa spectrin 
heterodimers and intact red cell membranes 
 To evaluate the feasibility of using our software and data acquisition strategy to 
analyze large protein complexes, crosslinking experiments using EDC/sulfo-NHS were 
performed using freshly isolated spectrin heterodimers purified from human red cells.  
Reactions were quenched at 15, 30, 60, and 120 min timepoints to generate a time-series 
intensity profile for each peptide precursor. Enriched putative crosslink signals from all 
four timepoints were combined and analyzed together through the rest of the multi-tiered 
pipeline.  A total of 18 crosslinked peptides were identified that were present by either 
the 15 or 30 min timepoint (FIGURE 2-8A, TABLE 2-4).  The spectrin heterodimer is 
quite complex with 4,556 residues of unique sequence (526 kDa), and not surprisingly 
each observed precursor could be matched to an average of about 30 different theoretical 
crosslinks when a 5 ppm mass error was used.  Typically many of these theoretical 
crosslinked complexes yielded similar low-resolution GM scores (TABLE 2-5). However, 
when high-resolution MS/MS spectra with their reduced charge state ambiguity and 
increased mass accuracy were available, the correct crosslink assignment was usually 
readily singled out as illustrated by the example in TABLE 2-5. 
 In subsequent proof-of-principle analyses of even larger complexes, EDC/sulfo-
NHS was used to crosslink intact human red cell membranes as well as the membrane 
cytoskeleton, which is a subset of the intact membrane containing spectrin, actin, and 
other associated proteins.  Importantly, the entire crosslinked membrane or cytoskeleton 
sample was digested with trypsin and analyzed by LC-MS/MS, in contrast to the 
experiments above, where crosslinked complexes were greatly enriched by isolation 
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FIGURE 2-8 Zero-length crosslink analysis of spectrin. 
Because the crystal structure of the entire protein is unavailable, approximate locations of 
identified crosslinks are plotted on the widely-accepted schematic of spectrin domain 
structure (82, 92).  As indicated, the long highly flexible α and β chains laterally associate 
laterally along the length of both chains.  Crosslinks that fit the known domain structure 
and lateral alignment of the subunits are indicated by red lines, while those indicative of 
the protein folding back upon itself are shown by dashed blue lines.  (A) Purified 
heterodimers in solution. (B) Intact membranes and isolated membrane cytoskeletons 
combined. 
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Charge M+H Sequence Domain 
Purified spectrin heterodimer 
 
4,5 2799.5039 ADVVEAWIADK-HLLEVEDLLQKHK α19-β3 
3 1763.9174 DFLEELEESR-ALGKK β5-β5 
4 3671.8910 DGLNEM#WADLLELIDTR-LLEVLSGEM#LPKPTK β14-ABD* 
3 3486.6290 DLEELEEWISEM#LPTACDESYK-KLSGLER α15-β7 
5 3551.8268 EFSTIYK-AYFLDGSLLKETGTLESQLEANKR EF-EF 
4 4089.9774 EKEPIVDNTNYGADEEAAGALLKK-DLEDETLWVEER α9-β12 
3 2003.9920 ETDDLEQWISEK-PTKGK β14-ABD* 
5 3209.5935 ETDDLEQWISEK-RKLENM#YHLFQLK β14-β14 
5 3498.7063 ETDDLEQWISEK-YFYTGAEILGLIDEKHR β14-β15 
4 2768.3413 FDEFQK-KAENTGVELDDVWELQK α11-α11 
3,4 2899.4578 GQQLVEAAEIDCQDLEER-AKLQISR β12-β12 
4 2409.2997 KHGLLESAVAAR-VDNVNAFIER α7-β14 
3 2083.0342 LADDEDYK-VQKQQVFEK α6-α6 
5 3716.7245 LSESHPDATEDLQR-FTEGKGYQPCDPQVIQDR α12-β3* 
4 2515.3231 NWINKK-YFYTGAEILGLIDEK α6-β15 
5 3348.7182 QDTLDASLQSFQQER-HLLEVEDLLQKHK α19-β3 
3,5 3128.5745 SSDEIENAFQALAEGK-VGKVIDHAIETEK EF-ABD 
4 3162.5890 YNEFLLAYEAGDMLEWIQEK-M#LAKLK α11-β11 
    
Intact Red Cell Membrane 
 
4 3132.5832 QEAFLENEDLGNSLGSAEALLQK-EKAATR α5-α5 
3,4 3470.6341 DLEELEEWISEMLPTACDESYK-KLSGLER α15-β7 
4 2846.5044 VQKQQVFEK-YFYTGAEILGLIDEK α6-β15 
4 3480.6015 SHLSGYDYVGFTNSYFGN]-ANNQKVYTPHDGK EF-ABD 
3,4 2931.4134 GQQLVEAAEIDCQDLEER-KQLESSR β12-β12 
3,4 2899.4578 GQQLVEAAEIDCQDLEER-AKLQISR β12-β12 
    
Isolated Membrane Cytoskeleton  
4 1845.0236 DIQNLK-VQKQQVFEK α6-α6 
4 3146.5941 YNEFLLAYEAGDMLEWIQEK-MLAKLK α11-β11 
4 2515.3231 NWINKK-YFYTGAEILGLIDEK α6-β15 
4 2899.4578 GQQLVEAAEIDCQDLEER-AKLQISR β12-β12 
4 2931.4134 GQQLVEAAEIDCQDLEER-KQLESSR β12-β12 
3 1546.8600 LSGLER-WITDKTK β7-β7 
 
TABLE 2-4 Spectrin crosslinks. 
Asterisks indicate crosslinks that are not consistent with the current understanding of 
spectrin domain structure and molecular shape. # indicates oxidized Methionine 
(+15.99492). All Cysteines are carboxyamidomethylated (+57.02146).  
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# 
m/z 
(theoretical) 
Sequence 
Mass 
Error 
(ppm) 
Low-
Res GM 
High-Res 
GM 
1 603.078408 QIAER-HKLMEADIAIQGDKVK 3.82 0.50 0 
2 603.078410 EDMK-DLASAGNLLKKHQLLER 3.81 0.53 0 
3 603.078410 KNNEK-HKLMEADIAIQGDKVK 3.81 0.45 0 
4 603.078745 RWEQLLEASAVHR-PTKGKMR 3.26 0.45 0 
5 603.079368 DKAAVGQEEIQLR-EAAAGRLQR 2.22 0.54 0 
6 603.079373 LEQLAR-EKTQHLSAARSSDLR 2.22 0.50 0 
7 603.079415 EFRSCLR-FAALEKPTTLELK 2.15 0.44 0 
8 603.080373 KHGLLESAVAAR-VDNVNAFIER 0.56 0.70 0.48 
9 603.080375 KLLNRHR-EADDTKEWIEKK 0.55 0.52 0 
10 603.080378 DLQGVQNLLKKHK-STASWAER 0.55 0.45 0 
11 603.080378 LQAVKLER-ANNQKVYTPHDGK 0.55 0.48 0 
12 603.080378 RQEVLTR-TWKHLSDIIEER 0.55 0.43 0 
13 603.081048 LGDYANLK-WITDKTKVVESTK 0.56 0.49 0 
14 603.081218 QEVLTR-DEEGAIVMLKRHLR 0.85 0.52 0 
15 603.081220 IQEITER-KHQLLEREMLAR 0.85 0.46 0 
16 603.081383 YQSFKER-WKALKAQLIDER 1.12 0.49 0 
17 603.081385 RQEVLTRYQSFK-PPKFQEK 1.13 0.48 0 
18 603.082183 QKALSNAANLQR-RVEDQVNVR 2.45 0.53 0 
19 603.082850 TQLEQSK-RVGKVIDHAIETEK 3.56 0.46 0 
20 603.082850 VGKVIDHAIETEK-TQLEQSKR 3.56 0.52 0 
21 603.083183 EAAAGRLQR-LQGQVDKHYAGLK 4.11 0.52 0 
22 603.083183 GLAEVQNRLRK-HKAFEDELR 4.11 0.48 0 
23 603.083183 GLAEVQNRLR-KHKAFEDELR 4.11 0.48 0 
24 603.083183 LRKHGLLESAVAAR-STASWAER 4.11 0.57 0 
25 603.083185 KLNEASRQQR-DGLAFNALIHK 4.11 0.58 0 
26 603.083185 QNEVNAAWERLR-EPLATRKK 4.11 0.46 0 
27 603.083190 RQEVLTRYQSFK-KDNVNKR 4.12 0.44 0 
 
TABLE 2-5 Power of high-resolution MS/MS data when applied to large protein 
complexes. 
Out of 27 theoretical crosslinks with m/z within 5ppm of the observed m/z of 603.0810 
and with low-resolution GM score of at least 0.4, only one putative crosslink has a non-
zero GM score when high-resolution data is available (boldfaced and italicized).  
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on 1D SDS gels followed by excision of the pertinent band prior to trypsin digestion.  
LC-MS/MS data from the untreated controls of both samples were searched against a 
Uniref100 human database to identify the major protein components in these samples 
(see Experimental Procedures). 
Based on these results, the 29 major proteins found in the intact membrane control 
(TABLE 2-6) and the 19 major proteins in the isolated membrane cytoskeleton (TABLE 
2-7) were incorporated into databases for analysis of crosslinked membranes and 
cytoskeletons, respectively.  Relative proteins abundances in the control samples were 
ranked by spectral counts normalized to molecular weight.  Due to the greater complexity 
of these samples, 4-hr LC gradients were used for both the discovery and targeted LC-
MS/MS runs.  Only two targeted runs were needed for the intact membrane sample and 
one targeted run was used for the isolated membrane cytoskeleton.  Despite the lack of a 
crosslinked protein enrichment step and the much greater protein complexity, we were 
able to identify 9 spectrin-spectrin crosslink precursors corresponding to 6 unique peptide 
sequences in the intact membrane sample (TABLE 2-4) and 20 additional crosslinks 
involving other membrane proteins.  For the isolated membrane cytoskeleton sample, 6 
spectrin-spectrin crosslinked precursors corresponding to 6 unique peptide sequences 
were identified (TABLE 2-4) and 6 additional crosslinks involving other proteins were 
identified.  The FDR for both datasets were estimated to be less than 1% (FIGURE 2-9) 
and all spectrin-spectrin crosslinks identified in either the intact membranes or the 
membrane cytoskeleton are in good agreement with current knowledge of the molecular 
topography of spectrin (FIGURE 2-8B). 
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2.2.6 Graphical Evaluation of Identified Crosslinks 
Finally, the ability to determine the exact crosslinked residues in crosslinked complexes 
containing more than one potential crosslink site candidate is essential for converting 
each identified crosslinked peptide complex into distance constraints to support 
molecular modeling and docking models. This issue is especially important for zero-
length crosslink datasets induced by EDC because often at least one of the peptides and 
sometimes both peptides contain multiple internal crosslinkable residues.  For example, 
the crosslinked complex shown in Error! Reference source not found.A has six 
alternative linkages and a number of these will have very similar MS/MS spectra that 
differ by only a few ions.  To facilitate manual review of assigned crosslinks, ZXMiner 
annotates crosslinked sequences and MS/MS spectra with color-coded b- and y-ions to 
distinguish between those that contain the crosslinked residues and those that do not.  
Error! Reference source not found.B shows the annotated spectra for the correct 
linkage of the peptides shown in Error! Reference source not found.A.  To further aid 
manual validation of alternative linkage sites, ZXMiner provides a graphical comparison 
mode where common and unique b- and y-ions and their relative intensities are color-
coded for the highest scoring alternative linkages (Error! Reference source not 
found.C). 
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Uniprot ID Protein Description 
Peptide 
Count 
Spectral 
Count 
Sequence 
Coverage (%) 
Sequence 
Length 
M.W. 
(kDa) 
P04406 Glyceraldehyde-3-phosphate dehydrogenase 13 123 55.2 335 36 
P02730 Band 3 anion transport protein 25 323 45.7 912 102 
P02549 Spectrin alpha chain, erythrocyte 115 593 60.5 2419 280 
P11277 Spectrin beta chain, erythrocyte 108 537 55 2137 268 
P16157 Ankyrin-1 68 365 58.9 1881 217 
P69905 Hemoglobin subunit alpha 6 21 62.7 142 15 
P11171 Protein 4.1 23 131 38.9 864 97 
P68871 Hemoglobin subunit beta 9 20 67.3 147 16 
P60712;P63261 Actin, cytoplasmic 1;Actin, cytoplasmic 2 18 50 56 375 42 
P16452 Erythrocyte membrane protein band 4.2 20 79 43 691 77 
P27105 Erythrocyte band 7 integral membrane protein 10 27 38.5 288 32 
Q08495 Dematin 12 25 41.3 405 46 
P11166 
Solute carrier family 2, facilitated glucose transporter 
member 1 
10 24 23.8 492 54 
Q00013 55 kDa erythrocyte membrane protein 12 22 41 466 52 
P35612 Beta-adducin 21 33 44.1 726 81 
O75955 Flotillin-1 10 18 36.3 427 47 
P28289 Tropomodulin-1 11 14 38.2 359 41 
P35611 Alpha-adducin 13 28 33.6 737 81 
Q9UKV8 Protein argonaute-2 18 26 32 859 97 
E7EMK3 Flotillin-2 8 14 23.8 483 53 
Q96PL5 Erythroid membrane-associated protein 8 12 29.7 475 53 
P11142 Heat shock cognate 71 kDa protein 13 14 38.9 646 71 
Q00610 Clathrin heavy chain 1 31 37 34.7 1675 192 
B5U6Z5 Kell blood group glycoprotein 12 16 26.4 732 83 
P55072 Transitional endoplasmic reticulum ATPase 14 17 33.3 806 89 
P08107 Heat shock 70 kDa protein 1A/1B 9 10 28.2 641 70 
Q13200 26S proteasome non-ATPase regulatory subunit 2 10 12 19.9 908 100 
K7BW74 26S proteasome non-ATPase regulatory subunit 1 10 10 21 959 107 
 
TABLE 2-6 The 29 most abundant proteins found in the intact membrane sample. 
Proteins were required to have at least 5 peptides and 10 spectral counts in the analysis of 
the untreated control sample. Proteins were than ranked by relative abundance based on 
spectral count normalized to molecular weight (M.W.).  
52 
 
Uniprot ID Protein Description 
Peptide 
Count 
Spectral 
Count 
Sequence 
Coverage (%) 
Sequence 
Length 
M.W. 
(kDa) 
P02549 Spectrin alpha chain, erythrocyte 118 525 60.5 2419 280 
P11277 Spectrin beta chain, erythrocyte 110 497 55 2137 268 
P60712;P63261 Actin, cytoplasmic 1;Actin, cytoplasmic 2 20 45 56 375 42 
P02730 Band 3 anion transport protein 26 107 45.7 912 102 
P16157 Ankyrin-1 67 182 58.9 1881 217 
P11171 Protein 4.1 13 46 38.9 864 97 
O75955 Flotillin-1 8 15 36.3 427 47 
P27105 Erythrocyte band 7 integral membrane protein 8 9 38.5 288 32 
P16452 Erythrocyte membrane protein band 4.2 15 21 43 691 77 
E7EMK3 Flotillin-2 8 10 23.8 483 53 
P28289 Tropomodulin-1 5 7 38.2 359 41 
P11142 Heat shock cognate 71 kDa protein 11 11 38.9 646 71 
P35611 Alpha-adducin 8 12 33.6 737 81 
Q96PL5 Erythroid membrane-associated protein 5 6 29.7 475 53 
B5U6Z5 Kell blood group glycoprotein 6 8 26.4 732 83 
P35612 Beta-adducin 5 7 44.1 726 81 
Q9UKV8 Protein argonaute-2 5 5 32 859 97 
P35579 Myosin-9 9 9 12.9 1960 227 
 
TABLE 2-7 The 19 most abundant proteins found in the membrane cytoskeleton. 
Proteins were required to have at least 5 peptides and 5 spectral counts in the analysis of 
the untreated control sample. Proteins were than ranked by relative abundance based on 
spectral count normalized to molecular weight (M.W.).  
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FIGURE 2-9 False discovery rates for the intact red cell membrane and isolated 
membrane cytoskeleton samples. 
FDR was normally calculated by counting the number of decoy crosslink hits. Adjusted FDR 
took into account the inherent bias between reverse-reverse decoy crosslinks and reverse-forward 
decoy crosslinks as described in (108). Asterisks mark the location of GM scores corresponding 
to < 1% FDR that were used as cutoffs for crosslink identification. (A) Intact membrane. (B) 
Isolated membrane cytoskeleton. 
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(See figure caption on the next page)  
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FIGURE 2-10 Graphical annotations of candidate crosslinks. 
(A) Example of a crosslink with multiple possible linkages. (B) ZXMiner annotates each 
candidate crosslink to the matched MS/MS spectrum with identified b- and y-ions (red 
and blue labels, respectively). Contributions from each peptide are separated into two 
panels to individually annotate b-ions and y-ions from the two crosslinked peptides. 
Peaks that match the crosslinked peptide are highlighted in green. (C) A detailed 
graphical comparison mode of ZXMiner facilitates comprehensive side-by-side 
evaluation of alternative crosslinked sites within the VAPEEHPTLLTEAPLNPK-KGK 
crosslinked peptide complex. Uninformative peak assignments shared by all possible 
linkages are colored in green while linkage-specific fragments are color-coded according 
to their relative intensity percentiles  
 
2.3 Discussion 
It is important to facilitate the use of zero-length crosslink analysis because the 
tightest distance constraints between amino acid residues are the most advantageous for 
structural model verification and refinement. So far, longer crosslinking reagents have 
been more frequently used, and most studies that utilized zero-length crosslinking were 
restricted to relatively small protein complexes due to difficulty of analyzing zero-length 
crosslink data.  This hurdle has been removed with the development of our multi-tiered 
LC-MS/MS strategy and ZXMiner software as it can automatically analyze data and 
assign sequences with very high accuracy and good depth of analysis.  Graphical tools 
facilitate optional review of assigned sequences and alternative complexes for 
confirmation but are not needed for initial crosslink assignments. The scoring system 
derived here, the GM score, is relatively simple but effective, even when megadalton 
complexes are analyzed.  Attempts to construct a better scoring function using linear 
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discriminant analysis (LDA) – a technique which has been previously utilized for  Lys-
Lys crosslink datasets (34) – achieved only marginal improvements here. With LDA, the 
area under the ROC curve for the GST dataset increased to 0.996, and 86.67% sensitivity 
could be achieved with no false positives. On the other hand, logistic regressions and 
nested model analyses of the three coverage scores that comprise the GM score as well as 
the GM score revealed that the optimal predictor was obtained when only Peak Coverage, 
Ion Coverage, and GM score were considered. This resulted in 0.999 area under the ROC 
curve and as high as 96.67% sensitivity was achieved without any false positives. Nested 
model analyses using deviance (109) showed that this improvement over the GM score-
only model is significant with a p-value of 0.0051.  Further evaluation of this program 
using diverse protein problems and other mass spectrometers are required to determine 
the generalizability of this alternative scoring model as some differences in optimal 
scoring strategies may occur when different types of mass spectrometers are utilized. 
 One potential limitation of the workflow proposed here is the need for multiple 
LC-MS/MS acquisitions, which can be an important consideration when the amount of 
crosslinked sample is limited, as might be the case when low yield crosslinked complexes 
are cut out of 1D SDS gels. However, a number of strategies can be utilized to limit the 
number of LC-MS/MS runs to one discovery run and one or two targeted LC-MS/MS 
runs.  First, while we typically use a conservative preliminary GM score cutoff of 0.4 to 
avoid loss of potential crosslinked peptide identifications, higher scores can be used.  For 
example, the low-resolution MS/MS data resulted in four targeted LC-MS/MS runs in the 
case of the GST in early studies, but subsequent analyses showed that this threshold 
could be raised to 0.5 without any negative impact on the crosslink identification 
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performance. Raising the preliminary low resolution MS/MS score from 0.4 to 0.5 cuts 
the number of required targeted runs by half for most datasets. In general, this GM score 
threshold can be freely adjusted to achieve a desired balance between throughput and 
depth of analysis. Additionally, the gradient length can be increased to reduce the number 
of targeted runs needed and thereby conserve samples available in limited amounts, as 
longer gradients can accommodate more target precursors per run. Noticeably, when a 4-
hr gradient was used for the spectrin heterodimer, isolated membrane cytoskeleton, and 
intact red cell membrane samples, no more than two targeted LC-MS/MS runs were 
required per sample.  
 The comparison with existing crosslink analysis software tools revealed that, at 
least in the context of the GST dataset, ZXMiner shows very favorable performance with 
more true positive identifications at both the unqiue precursor and unique sequence levels 
and a lower actual false discovery rate (TABLE 2-3).  Possible reasons why these 
alternative software packages did not perform well here is because most of them were 
optimized using datasets generated with different crosslinkers and in a few cases with 
different types of mass spectrometers.  Specifically, MassMatrix and pLink were 
developed using BS
3
, while StavroX considered BS
2
G, disulfide bonds, and SBC – an 
amine-reactive photo-crosslinker. Although Crux was optimized using an EDC zero-
length crosslink dataset, due to software design limitations, it was unable to identify any 
of the ten true positive crosslinks in the GST dataset that had oxidized methionine.  
Interestingly, most crosslinks identified by a single program were false positives (13 of 
15 at the unique sequence level) while most of those identified by at least three programs 
were correct identifications (12 out of 14 at the unique sequence level) (FIGURE 2-7). 
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Hence, as with identification of linear peptides, one can improve depth of analysis and 
simultaneously reduce false positives by reporting crosslinks identified across multiple 
software packages. In this regard, all of the crosslinks reported by ZXMiner were also 
identified by at least one other program, and all but one were identified by at least two 
others. 
 Although good depth of analysis is highly desirable in crosslink experiments, for 
most applications, the most critical factor is a very low FDR, because even a single false 
positive crosslink can have profound negative effects.  Incorrect crosslink assignments 
will usually erroneously indicate protein-protein proximity, including an interaction 
between two proteins that does not exist, and when used to support structural models, 
incorrect distance constraints will reduce the accuracy of structural model.  As noted 
above, some programs use a fixed 5% FDR and with programs where this is adjustable, 
an FDR of 5% is often used.  Furthermore, as shown in Table 2, the actual FDR at the 
unique sequence level is far higher than the FDR selected in the analysis.  Given the 
negative impact of incorrect assignments, we feel that the actual FDR must be less 
than1%, and preferably should be 0%.  The results shown here indicate that our multi-tier 
analysis strategy with ZXMiner can effectively achieve such low FDR levels while 
retaining excellent depth of analysis.  
  The feasibility of applying our zero-length crosslink analysis strategy to 
interrogate large protein complexes was demonstrated by analyses of 526 kDa spectrin 
heterodimers, isolated red cell membrane cytoskeletons, and the intact red cell 
membranes. The latter two samples represent by far the most complex zero-length 
crosslink dataset to date, as their analysis involved databases with more than 2,000 kDa 
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of unique sequence. A low false discovery rate (< 1%) was maintained throughout, and 
the majority of the crosslinks identified in the spectrin heterodimer dataset and all 
spectrin-spectrin crosslinks in the other two are in good agreement with the known 
general topography of the protein (FIGURE 2-8). Interestingly, three crosslinks were 
observed in the spectrin heterodimer experiment between sites on the molecule that are 
thought to be large distances from either other (blue dashed lines in FIGURE 2-8A).  The 
most likely explanation for these unexpected crosslinks is that because isolated spectrin 
heterodimers are highly flexible, extended, worm-like molecules, such folding back upon 
itself may be an artifact of the increased molecular freedom that occurs in the isolated 
molecules in solution.  Another possibility is that these crosslinks are due to random 
interactions between two separate dimer molecules, although this does not seem likely as 
crosslinking of other proteins at similar protein concentrations did not typically show 
significant inter-molecule crosslinking.  Finally, it is possible, but not likely, that “known” 
concepts of spectrin domain topography are incorrect.  Interestingly, in support of the 
first explanation, similar unexpected spectrin crosslinks were observed when non-zero-
length crosslinkers were utilized on heterodimer in solution, but not in the intact 
membrane or the membrane cytoskeleton.  These differences could be attributed to the 
fact that spectrin is sequestered in a large two-dimensional lattice when on the membrane 
or in purified membrane cytoskeletons.  However, it is also possible that these 
unexpected crosslinks were not detected due to the decreased depth of analysis achieved 
in the far more complex membrane and cytoskeleton samples.  Future experiments will 
be designed to distinguish between the alternative explanations for the long range 
crosslinks. 
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2.4 Materials and Methods 
GST and myoglobin crosslinking 
 GST was purified after cleavage from a fusion protein as previously described 
(92) and myoglobin was purchased from Sigma-Aldrich. Crosslink reactions of GST (0.3 
mg/ml) and myoglobin (0.4 mg/ml) were performed at 0˚C using 25 mM EDC /12.5 mM 
sulfo-NHS and 10 mM EDC / 5 mM sulfo-NHS, respectively. Aliquots of the crosslinked 
products were removed after 60 min of reaction time, quenched by the addition of 
dithiothreitol, and subsequently buffer exchanged and concentrated on 10K MWCO 
filters. Crosslinked and untreated control samples were separated on SDS gels stained 
with colloidal Coomassie Blue. Bands of interest were excised, alkylated, and digested 
with trypsin as previously described (110). Tryptic digests were lyophilized and 
resuspended in 0.1% formic acid in MilliQ water at an estimated concentration of 0.1 
μg/μL based on gel stain intensity. 
Spectrin heterodimer crosslinking 
 Spectrin heterodimers were isolated as previously described (80) from fresh blood 
obtained from healthy volunteer human donors using informed consent and under a 
protocol approved by an institutional review board. Prior to crosslinking, spectrin dimers 
were isolated in 10mM sodium phosphate, 130 mM sodium chloride at pH 7.4 by gel 
filtration using three G5000PWXL columns connected in series and maintained at 4
o
C. 
Sample concentration was then adjusted to 0.2 mg/ml. Crosslinking reactions were 
carried out at 0
o
C with 5 mM EDC / 2.5 mM sulfo-NHS, respectively. Aliquots were 
removed at 15, 30, 60, and 120 min and quenched by addition of 20 mM dithiothreitol 
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(final concentration) with incubation for 15 min at reaction temperature. Samples were 
buffer exchanged, concentrated using an Amicon Ultra 50K filtration unit, and separated 
on 3-8% Tris-Acetate mini-gels in Tris acetate running buffer. Bands corresponding to 
the molecular weight of dimer were excised, alkylated, and digested with trypsin. Tryptic 
digests were lyophilized and resuspended in 0.1% formic acid in MilliQ water at an 
estimated concentration of 0.1 μg/μL based on gel stain intensity. 
Crosslinking of human red cell membranes 
 Membrane cytoskeletons and intact human red cell membranes were isolated 
essentially as previously described (80, 111).  Crosslinking of the intact membrane was 
performed in cell lysis buffer (5 mM sodium phosphate, 1 mM EDTA, 0.1 mM DFP, pH 
8.0). Crosslinking of the cytoskeleton was performed in 20 mM HEPES, 125 mM NaCl, 
3.75 mM CaCl2, 2.5 mM MgCl2, at pH 7.4. Both sets of reactions were carried out at 0.5 
mg/ml protein concentration at 0˚C using 10 mM EDC / 5 mM sulfo-NHS. Aliquots were 
removed and quenched with dithiothreitol at 15 min and 30 min for the intact membrane 
sample, and at 15 min, 60 min, and 120 min for the cytoskeleton sample. 200 µg of each 
of the control and crosslinked samples was digested with trypsin using the FASP method 
(112). 
Construction of protein databases for red cell membrane samples 
 Each untreated control of the intact membrane and isolated membrane 
cytoskeleton was searched using MaxQuant version 1.3.0.5 (113) against a Uniref100 
human database (March 2013, Protein Information Resource, Georgetown University, 
Washington DC) combined with a list of common contaminant (trypsin, keratins, etc.) 
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and a decoy database prepared by reversing each protein sequence. The combined 
database has a total of 234,648 entries. MS/MS spectra were searched using trypsin 
specificity without the Pro restriction with up to three missed cleavages, a 10 ppm 
precursor mass tolerance, 0.5 amu fragment ion mass tolerance, static modification of 
Cys (carboxamidomethylation +57.02146 Da), and up to three variable modifications for 
Met oxidation (+15.99492 Da) and protein N-terminal acetylation (+42.01056 Da). 
Minimum peptide length was set at 7 residues. Consensus protein lists were generated 
with false discovery rates (FDR) of <1% at both peptide and protein levels. Peptides 
common between multiple protein groups were re-assigned solely to the group with the 
highest number of peptides. Proteins were required to be identified by at least 2 peptides. 
Mass spectrometry  
 Tryptic digests of crosslinked and untreated control samples were analyzed on an 
LTQ-Orbitrap XL (Thermo Scientific, Waltham, MA) coupled to a NanoACQUITY 
UPLC system (Waters, Milford, MA) with a column heater maintained at 40
o
C. The 
specification of the UPLC system, the buffer, and the 85-min gradient used for GST and 
myoglobin samples was set as previously described (114). Details for the 4-hr gradient 
used for spectrin heterodimer samples were as described in (115). The injection volume 
for each crosslinked sample was adjusted to maintain a consistent load of about 0.5 μg 
total peptides. The mass spectrometer was set to scan over the 400-2000 m/z range. 
During the first round of LC-MS/MS acquisition (discovery, low-resolution MS/MS), full 
scans were acquired in the Orbitrap in profile mode at 60,000 resolution followed by data 
dependent MS/MS scans in the LTQ ion trap for the six most abundant ions. 
Monoisotopic precursor selection was enabled and charge state screening was activated 
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to reject +1 and +2 precursors. Dynamic exclusion was set for the duration of 45 sec on 
an 85-min run or 120 sec on a 4-hr run after a repeat count of 1. AGC targets were set at 
10
6
 for full MS scans with a maximum injection time of 500 ms, and at 10
4
 with a 
maximum injection time of 100 ms for MS/MS scans. Isolation window width was set at 
2.5 amu. For the subsequent targeted high-resolution LC-MS/MS runs, both full MS and 
dependent MS/MS scans were acquired at 15,000 resolution. Monoisotopic precursor 
selection was disabled and the dynamic exclusion duration was reduced to 12 sec. 
Isolation window width was raised to 4.0 amu to compensate for increased space 
charging. Minimum signal threshold for triggering MS/MS scans was set at 50,000 ion 
counts. The AGC target for MS/MS scans in the Orbitrap was set at 10
5
 with a maximum 
injection time of 500 ms. 
Label-free comparison 
 In this study, Rosetta Elucidator software (version 3.1, Rosetta Biosoftware, 
Seattle, WA) was utilized to perform label-free quantitative comparisons of discovery 
LC-MS/MS data, although any label-free quantitative comparison software capable of 
aligning and comparing LC-MS data should be applicable. First, LC-MS data was 
trimmed to the region containing significant peptides.  Generally this involved deleting 
the first 10-15 min and the last 10-15 min, which contained mostly noise. Parameters for 
the retention time alignment and feature (discrete precursor m/z signal) identification 
were set as previously described (114, 116), with the addition of the following filters: 
peak time score ≥ 0.7, peak m/z score ≥ 0.8, and charge state from 3 to 5. Then, the label-
free quantitation data at isotope group level, where each isotopic envelope was collapsed 
into a  monoisotopic m/z and charge state, and precursor signals that are at least 10-fold 
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enriched in a crosslinked sample compare to the corresponding control were designated 
as putative crosslinks. 
ZXMiner software 
 The ZXMiner was developed to expedite data acquisition stages, to process LC-
MS/MS data, and to identify crosslinked peptides, as highlighted in the diagram in 
FIGURE 2-1. To match observed m/z precursors to theoretical crossslinks, the masses of 
putative crosslinks defined by label-free quantitation were compared to the list of 
theoretical crosslink masses by ZXMiner using 5 ppm mass tolerance when the LC-MS 
data was obtained at 60,000 resolution, and 15 ppm for 15,000 resolution data. 
Theoretical crosslinked peptides were generated in silico by ZXMiner based on an input 
amino acid sequence database, protease reactivity, and expected crosslinker chemistry 
(trypsin and EDC, i.e. amines to carboxyl groups, in our case). A database consisted of 
only target protein sequences was considered for the purpose of determining putative 
crosslinks, and a decoy database was later added when final crosslink identifications were 
made, as indicated in FIGURE 2-1. Full tryptic specificity was used. A static 
Carbamidomethyl modification for cysteine (+57.02146 Da) and variable oxidation of 
methionine (+15.99492 Da) were considered. Two or three incomplete cleavages were 
allowed and individual peptide size was limited to 5-50 amino acids for linear peptides 
prior to considering crosslinking thereof. 
 To match MS/MS spectra to theoretical peptides, putative crosslinks where 
precursor ions matched to theoretical crosslink precursor ion m/z values were further 
evaluated by ZXMiner.  Low-resolution MS/MS spectra from the initial discovery LC-
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MS/MS run were pre-processed by applying a peak intensity threshold of 10 ion counts. 
High-resolution MS/MS spectra were subjected to two pre-processing steps: applying a 
peak intensity threshold of 1,000 ion counts and de-isotoping. Our de-isotoping strategy 
was implemented as described in (113, 117). Mass tolerance for the isotopic window 
spacing was set at 20 ppm and a cutoff of 0.6 was used for the Chi-square test when 
comparing observed intensity profile of an isotopic envelope to the expected pattern 
derived from averagine.  For linear peptides, all theoretical b-ions and y-ions were 
generated and compared to observed spectra. For crosslinked peptide, all possible 
locations of the crosslinked site and their corresponding b-ions and y-ions were 
calculated. Ions containing less than six amino acids were assigned a charge state of +1. 
Ions containing more than 12 amino acids and ions containing the crosslinked site with 
intact partner peptide were assigned a minimum charge state of +2. Ions not containing 
the crosslinked site were not allowed to attain the precursor charge state. All other ions 
were allowed to assume any charge state from +1 up to the precursor charge state. The 
list of theoretical b-ion and y-ion m/z values generated using these rules was then 
compared to the m/z peaks in the preprocessed MS/MS spectrum. Mass tolerance was set 
to 0.5 Da for low-resolution data and 15 ppm for high-resolution data. If multiple 
theoretical ions matched up to the same observed m/z peak, the alternative with the 
smallest mass error was selected. After all possible b-ion and y-ion matches had been 
assigned, neutral losses of the matched ions were generated and compared to the 
remaining unmatched observed m/z peaks. For low-resolution MS/MS data, up to only 
one neutral loss of water and one neutral loss of ammonia were considered. Up to two 
neutral losses were allowed for the precursor ions. For high-resolution data, these limits 
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were doubled. For a-ions, a1 to a5 were considered. Neutral loss of CH3SOH from the 
precursor ion was taken into account when oxidized methionine was present, as this loss 
was frequently observed. In addition, the m/z for the C13 ion was generated for low-
resolution data since isotopic envelopes could not be detected and collapsed and for 
larger peptides, the C13 ion sometimes predominated. 
 To score the quality of matches between observed and theoretical MS/MS spectra, 
three scoring functions were used to evaluate the correlation between theoretical b-ion 
and y-ions and observed m/z peaks in the MS/MS spectrum, including: “Peak Coverage” 
which defines the proportion of observed peaks that matched to some theoretical ions, 
“Intensity Coverage” which describes the fraction of the total observed peak intensity that 
were explained by the theoretical ions, and “Ion Coverage” which corresponds to the 
proportion of the b-ions and y-ions that were found in the observed spectrum. For the 
purpose of computing Peak Coverage and Intensity Coverage from high-resolution 
MS/MS spectra, only peaks with intensity at least 5,000 ion counts (after de-isotoping) 
were considered. All peaks passing the 1,000 ion count threshold were considered when 
calculating Ion Coverage. The corresponding peak intensity thresholds for low-resolution 
MS/MS spectra were 50 and 10 ion counts, respectively. The geometric mean of these 
three scores (GM score) was then calculated and used to rank the quality of identification. 
For each observed MS/MS spectrum, the matched theoretical peptide with the highest 
GM score was reported as the identification. To collapse the result at the peptide level, 
the corresponding MS/MS spectrum with the highest GM score was reported for each 
identified crosslinked peptide (distinct sequence, charge state, or variable modification). 
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 The FDR was estimated using a decoy database of reversed target protein 
sequences. The formula for calculating the FDR, which takes into account the inherent 
bias in GM scores toward “hybrid” crosslinks – crosslinks consisting of one peptide from 
a target protein and another from a decoy sequence – compared to crosslinks involving 
two decoy sequences, was adapted from (108). 
Input parameters for StavroX, Crux, pLink, and MassMatrix 
StavroX v2.3.4 – The definition for EDC and trypsin without the proline 
restriction was added to the software. Up to two missed cleavages were allowed. A static 
Carbamidomethyl modification for cysteine and variable oxidation of methionine were 
selected. Mass tolerance was set at 10 ppm for the precursor and 0.5 Da for the fragment. 
Mass limit was set to be between 300-4000 Da. Signal-to-noise threshold was set at 1. A 
score cutoff of 50 was selected to control the FDR to within 5%. 
pLink (Feb 2013 release) – Enzyme, amino acid modifications, and precursor 
mass tolerance were set as described above. However, the number of missed cleavage 
could not be specified. Fragment mass tolerance was set at 15 ppm for high-resolution 
MS/MS data. Instrument fragmentation mode was set to CID. Maximal E-value was set 
at 1.00. FDR was automatically fixed at 5% within the software. 
Crux v1.40 – Enzyme and precursor mass tolerance were set as described above. 
Cysteine residues were considered as Carbamidomethyl modified. Minimal peptide 
length was set to five residues and up to two missed cleavages were allowed. 
Monoisotopic mass option was selected (as opposed to using average masses). Fragment 
mass tolerance and variable modification could not be specified. Also, crosslinking rules 
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involving the protein N- and C-terminus could not be defined. The outputted Bonferroni 
corrected FDR values were used to control the FDR to within 5%. 
MassMatrix v1.3.2 – Amino acid modifications and mass tolerances were set as 
generally described above. Peptide length limit was set to be 5-50 residues. Up to two 
missed cleavages were allowed. Minimal pp and pp_tag scores were set at 0.1 and 0.01, 
respectively as per the suggestion in the software’s manual for analyzing crosslink 
datasets. The definition of trypsin without the Proline restriction was selected. Due to the 
limitation on the allowed definition of crosslinker, crosslinking rules involving the 
protein N- and C-terminus could not be defined. Crosslink searches also had to be split 
into two separate runs – one with Lys-Asp crosslinking and another with Lys-Glu – and 
manually combined. 
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Chapter 3: Solving Medium-Resolution Structures for 
Wild-Type Mini-Spectrin Dimer and Tetramer 
 Spectrin is a major member of the erythrocyte membrane skeleton, providing 
integrity and elasticity to the membrane. Mini-spectrin, a 90 kDa recombinant protein 
containing the spectrin tetramer interface, was previously constructed in our laboratory as 
a model system for studying structural and functional properties of spectrin. Solving the 
structures of mini-spectrin dimer and tetramer are crucial steps toward this goal. Mini-
spectrin chemical crosslinking datasets obtained via our current pipeline were converted 
into distance constraints between the two involved alpha carbon atoms. MODELLER was 
then used to generate homology models of mini-spectrin dimer and tetramer, utilizing 
crosslink-derived distance constraints to guide and validate the modeling. In this chapter, 
we describe the details of the homology modeling and present the medium-resolution 
structures of wild-type mini-spectrin dimer and tetramer. 
3.1 Introduction 
Solving static structures of protein complexes and probing dynamic 
conformational rearrangements have frequently provided mechanistic insights into 
macromolecular function and effects of disease-related mutations. However, high-
resolution structural techniques such as X-ray crystallography and NMR usually cannot 
be applied to large proteins that are highly flexible, intrinsically disordered, or undergo 
large conformational changes.  Chemical crosslinking coupled with mass spectrometry 
(CX-MS) is a powerful tool that identifies proximal amino acid residues of proteins in 
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solution.  These distance constraints can greatly enhance and experimentally validate 
molecular modeling to result in reliable medium resolution structures.  This approach has 
been effectively utilized in numerous studies (27, 30-33), although homobifunctional 
lysine-specific crosslinkers with relatively long spacer-arms were usually used. Such 
reagents have been preferred because they enable introduction of isotope labels and other 
functional sites that facilitate crosslinked peptide identifications (20-22, 24).  In contrast, 
zero-length crosslinkers such as 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide (EDC) 
form a covalent bond between reactive amines and carboxyls without inserting extra 
atoms. This results in tighter distance constraints that outperform constraints from longer 
crosslinks when these data are used to refine structural models (21). 
In this chapter, we employed the strategy described in Chapter 2 to probe 
structures and conformational changes in spectrin, a highly flexible, dynamic protein with 
multiple functions that is typically associated with cell membranes.  In red cells, spectrin 
is the central component of a highly developed, two-dimensional, net-like 
submembraneous complex that confers both structural integrity and elasticity to the cell 
membrane.  The 1,052 kDa spectrin tetramer is a long, highly flexible worm-like protein 
comprised primarily of many tandem, homologous, “spectrin-type” domains (FIGURE 
3-1A).  In all reported crystal structures, these domains are about 50 Å long three-helix-
bundles with helical connectors (FIGURE 3-1B, FIGURE 3-1C).  So far, crystallization 
of more than four spectrin-type domains has not been feasible, presumably due to 
spectrin’s highly flexible nature.  In the membrane skeleton, spectrin tetramers bridge 
short actin oligomers, and membrane stability is highly dependent upon the dimer-
tetramer equilibrium because conversion to dimers severs bridges between actin 
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oligomers (70-71). The spectrin dimer-tetramer equilibrium actually involves three states 
including closed dimers, open dimers, and bivalent head-to-head tetramers (FIGURE 
3-1A).  Conversion from open to closed dimers involves a large conformational 
rearrangement of the longer α-subunit where it folds back upon itself and forms a head-
to-head association analogous to the head-to-head associations in tetramers (FIGURE 
3-1A).  Closed dimers play a critical, but poorly understood role in this equilibrium and 
are responsible for a high energy threshold that constrains kinetics of the dimer-tetramer 
equilibrium (83).  
 To provide a tractable model platform for studying structural and functional 
properties of spectrin, our group previously developed mini-spectrin (92), a 90 kDa 
recombinant protein containing the spectrin tetramerization site that closely mimics 
spectrin dimer-tetramer equilibrium. A previous preliminary model of mini-spectrin 
tetramer was developed (49), but it was supported by only one inter-strand crosslink and 
therefore warranted detailed re-examination. Our current zero-length crosslinking 
strategy more than doubled the number of identified crosslinked peptides. These newly 
identified crosslinks sufficiently defined a docking interface between the two mini-
spectrin strands and permitted refinement of the tetramer docking model. 
3.2 Results 
3.2.1 Refinement of Mini-Spectrin Tetramer Model 
 The current CX-MS experiments yielded more than twice as many crosslinks (29 
vs. 12 previously), and importantly, these included seven inter-strand crosslinks to better 
refine inter-subunit docking (FIGURE 3-1D). To model the wild-type tetramer, four 2-
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domain crystal structures (PDB ID: 1CUN, 1U5P, 3FB2, and 1S35) were used as the 
template for each pair of consecutive α-spectrin domains in mini-spectrin (α1-α2, α2-α3, 
and so on). The crystal structure for the β16-17/α0-1univalent tetramer complex (84) that 
was previously determined in our laboratory was used as the template for this region of 
the molecule (PDB ID: 3LBX). One hundred models were generated using MODELLER 
v9.11 (118-121) with the crosslink-derived distance constraints, and the model with the 
lowest average pairwise Root-Mean-Square Deviation (RMSD) was selected as the 
representative structure and subjected to further evaluation. Models were reasonably 
tightly clustered with average pairwise RMSD of 3.97Å, and the selected structure had an 
average pairwise RMSD of 2.95Å. In the final structure, all Cα-Cα distances between 
crosslinked residues were less than the ~12Å maximum distance defined by the lengths 
of crosslinked side chains.  Comparisons of the current and previous preliminary model 
show similar molecular shapes (FIGURE 3-1E). While there was an overall 14.7 Å 
RMSD between the structures, most differences were contributed by different docking 
orientations between the laterally-associated strands and larger gaps between strands in 
the earlier model (FIGURE 3-1F, FIGURE 3-2). These differences are not surprising as 
the prior model used only a single inter-strand distance constraint compared with seven in 
this study, and the accuracy of structures increases substantially as the number of distance 
constraints increase (21). 
 Interestingly, the tetramer dataset included a crosslink between the α3 and α4 
domains, which defines a kinked inter-domain propagation (FIGURE 3-1G) that is 
inconsistent with the rigid α-helical inter-domain connectors observed in all crystal 
structures.   This is significant because the structure in FIGURE 3-1E is consistent with 
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the extended molecular shape of spectrin (2000 Å long tetramers) (85) that is dictated by 
the helical connectors between adjacent domains.  However, this extended conformation 
only occurs when the protein is forcibly stretched or in low ionic strength buffers, 
whereas the physiological form of the protein is three times shorter, i.e., 650 Å tetramers 
(122).  These dramatic changes in molecular shape are thought to be due to super-coiling 
(90), which is incompatible with helical connectors.  The crosslink shown in FIGURE 
3-1G is the first biochemical evidence that connectors are not always helical.  By 
allowing the connector to be non-helical and applying this distance constraint, a kink is 
introduced at the connector and the adjacent domains are a roughly 90
o
 bend that fits well 
with models of super-coiling (90). 
3.2.2 Developing Mini-Spectrin Dimer Model 
 Our crosslinking strategy was subsequently applied to wild-type mini-spectrin 
dimer to elucidate medium resolution structures of this critically important form of the 
protein. Based upon existing knowledge of spectrin’s molecular shape and locations of 
binding sites, the inter-conversion of spectrin between tetramers, open dimers, and closed 
dimers must involve large conformational rearrangements as illustrated in (FIGURE 3-3A). 
However, very little is known about the properties of the two dimer conformations 
because there are no effective methods for directly detecting or quantitating the two 
forms. An initial structure-function analysis of mini-spectrin showed that the two species 
could be partially resolved on HPLC gel filtration columns and several crosslinks specific 
for either closed dimers or open dimers were detected (92). 
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(See figure caption on the next page) 
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FIGURE 3-1 Spectrin topography and mini-spectrin tetramer structure. 
(A) Schematic showing spectrin domains, the dimer-tetramer equilibria, and mini-
spectrin.  The spectrin-type domains that comprise most of the molecular are represented 
as rounded rectangles. Red asterisks in the mini-spectrin cartoon indicate the approximate 
location of the αL207P mutation. (B) The four crystal structures of spectrin-type domains 
(PBD ID: 1CUN, 1U5P, 3FB2, and 1S35) used as template building blocks for homology 
modeling. (C) Crystal structure for the spectrin tetramerization interface (PDB ID: 
3LBX). (D) Locations of inter-domain crosslinks used to model mini-spectrin tetramer; 
blue lines – crosslinks identified previously (49), red lines – new crosslinks. (E) 
Superimposition of current and previous tetramer structures. (F) Space-filling 
representations of tetramer models. Each color represents a laterally associated strand. 
(G) Evidence for a non-helical connector between α3 and α4, indicative of super-coiling; 
blue – Lys; red – Glu/Asp, green lines – crosslinks with Cα-Cα distances labeled. 
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FIGURE 3-2 Identified inter-strand crosslinks facilitate refinement of the tetramer model. 
The preliminary model in 2010 was constructed based only on one inter-strand crosslink 
(located at the regions marked by black triangles). Additional crosslinks (shown on both 
models by green lines and highlighted by arrows) allowed major refinement to the 
docking interface between the two mini-spectrin strands. Glu and Asp residues are 
colored in red. Lys residues are in blue. 
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A total of 32 crosslinks were identified. Eleven of these were not observed when 
tetramers were crosslinked, thereby indicating that they were reporting conformational 
rearrangements that occurred upon formation of dimers. Three crosslinks were consistent 
with an open dimer conformation and nine crosslinks fit a closed dimer conformation. In 
addition, 13 inter-domain crosslinks were identified that were consistent with either the 
closed or open conformation (FIGURE 3-3B). These latter constraints were used for 
subsequent homology modeling of mini-spectrin closed dimers. Several crosslinks in the 
closed dimers suggested sharp kinks across connector regions that could only be achieved 
if the connectors were not helical (FIGURE 3-3C).  Hence, to build the model, four 
residues in each connector region were allowed to adopt non-α-helical secondary 
structures. This resulted in higher degrees of freedom in the modeling and larger average 
pairwise RMSD of 9.34 Å among all one hundred models and 7.37 Å for the chosen 
structure, compared to those obtained for the tetramer.  However, visual inspection 
confirmed that the overall shapes and structural organizations were similar. Subsequently, 
the two crosslinks between the α0 and α1 domains indicative of the open dimer 
conformation were used to generate an independent model for the α0 and α1 domains, 
and this structure was stitched onto the closed dimer model as a likely open dimer model 
for comparative purposes (FIGURE 3-3D). Intermediate-state models were generated via 
the Morph Server (123) to illustrate putative intermediate structures between open dimers 
(half of the tetramer structure) and closed dimers (FIGURE 3-3E). These results provide a 
plausible, experimentally supported structure of closed spectrin dimers and the large 
conformational rearrangement involved in the open-closed dimer transition. 
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FIGURE 3-3 Conformational changes in the closed to open spectrin dimer transition. 
(A) Schematic showing the mini-spectrin dimer-tetramer equilibrium. (B) Dimer 
crosslinks: left panel – specific to the closed dimer conformation; middle panel – specific 
to the open dimer conformation; and right panel – inter-domain crosslinks used to 
develop the closed dimer homology model.  Dashed circles – estimated reach of the 
disordered N-terminal tail (yellow squiggle), red X’s – sites of crosslinks to α-subunit N-
terminal amines. (C) Dimer-specific crosslinks indicative of non-helical connectors 
before (left) and after (right) structural refinement; blue – Lys; red – Glu/Asp, green lines 
– crosslinks with Cα-Cα distances labeled.  (D) Open dimer model supported by two 
crosslinks between α0 and α1 domains. (E) Structures showing the inter-conversion 
between fully extended open dimer to closed dimer.  
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3.3 Discussions 
 The in-depth identifications and high confidence assignments of many zero-length 
crosslinks provided by our multi-tiered strategy were essential for building medium 
resolution, experimentally verified structures of multiple forms of spectrin dimers and 
tetramers. The importance of identifying crosslinks spread throughout a protein complex 
is illustrated by the substantial differences in the docking interface of mini-spectrin 
tetramers using a single inter-strand crosslink compared with the current model using 
seven inter-strand crosslinks. These structures correspond to the fully-extended 
conformation of spectrin-type proteins where all connector regions are helical and all 
domain-domain propagations are more or less linear. However, several crosslinks directly 
or indirectly indicative of the super-coiled conformation of the protein were also 
observed, including the one at the α3-α4 junction shown in FIGURE 3-1G. Other 
crosslinks include one that suggests a slight kink at the β16-β17 junction and two inter-
strand crosslinks at the α4-β17 interface between residues that only come within 
crosslinkable distances if the α3-α4 junction sharply bends. The latter crosslinks most 
likely coincide with the super-coiling at the α3-α4 junction. Unfortunately, as it is most 
likely that every domain-domain junction simultaneously assume a similar ~90
o
 bend 
when the protein super-coils, these crosslinks alone are not enough to support an 
immediate modeling of super-coiled mini-spectrin tetramer. Furthermore, because all 
existing crystal structures of spectrin-type proteins exhibit helical, linear connector 
regions, effectively modeling the super-coiled conformation could be beyond the capacity 
of homology modeling. 
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 Another challenge for homology modeling was the development of a mini-
spectrin closed dimer structure, as this conformation possesses a hairpin loop in the α1-
α2-α3 region that is very different from any available template crystal structures. The two 
connector regions at the α1-α2 and α2-α3 junctions must adopt ~90o bends to allow the α-
spectrin strand to fold back on itself and bind with the β17 domain. Three crosslinks also 
indicate kinks at the β16-β17 and α3-α4 junctions. Hence, in subsequent homology 
modeling of the closed dimer, residues around each connector region were allowed to 
adopt non-α-helical secondary structure to accommodate large deviations from the 
template crystal structures. This greatly increased the degree of freedom of the models 
and resulted in substantial average pairwise RMSD among the models generated (7-9 Å 
compared to 2-3Å for the tetramer model). As evident from the final model of the closed 
dimer (FIGURE 3-3E, the right-most structure), almost every consecutive domain-domain 
structure differs significantly from any known crystal structures (FIGURE 3-1B). 
However, despite the high average pairwise RMSD indicating that the one hundred 
homology models generated were quite variable, visual inspection of these models 
confirmed that the overall molecule shapes and domain structure organizations are 
consistent. And so, we believe that our closed dimer model is a decent representative 
structure for this conformation. 
 An important question that arose was how a model of the open dimer 
conformation should be developed. The only informative, clear-cut evidence for this 
conformation consists of two crosslinks linking the α0 domain to α1 – indicating that the 
α0 domain dissociates from β17 and folds back onto the α1 domain. The other crosslink 
involves the flexible α-N-terminal residue and is uninformative for modeling purposes. 
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Open dimer in a broad sense covers every state of the protein from the dissociation of the 
α0-β17 interaction in the closed dimer, to the association between the α0 and α1 domains, 
to the elongation of the α-strand in preparation for forming the tetramer (FIGURE 3-3E). 
Hence, in order to capture this important dynamic, homology modeling was used to 
derive models of four discrete states shown in FIGURE 3-3E followed by structure 
interpolations using the Morph Server (123). While these results provide only 
approximate views of the closed dimer-open dimer transition, they are the first 
experimentally-supported, structural insight into this important major physiological 
conformational rearrangement of spectrin. 
3.4 Materials and Methods 
 Crosslink data analyses were carried out as described in Chapter 2. 
Expression and purification of recombinant mini-spectrin 
 Expression, purification and functional properties of the WT mini-spectrin protein 
were previously described (92). Briefly, protein expression was carried out at 18
o
C in the 
BL21-Codon Plus (DE3)-RIPL strain of Escherichia coli.  After lysis by sonication, the 
soluble fraction was applied to glutathione Sepharose.  The eluted fusion protein was 
digested with thrombin to remove the GST tag.  The sample was reapplied to the 
glutathione Sepharose to column to remove GST and any undigested fusion protein.  The 
flow-through fraction was further purified using a HiLoad 200 column equilibrated in 
10mM sodium phosphate, 130 mM sodium chloride, 1mM EDTA, 0.15mM PMSF, 1mM 
2-mercaptoethanol, pH 7.4. 
Crosslinking protocols and LC-MS sample preparation 
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Mini-spectrin dimers and tetramers were buffer exchanged into 10 mM sodium 
phosphate, 130 mM sodium chloride using two G4000SWXL BioAssist columns 
connected in series and maintained at 4
o
C.  The final sample concentration was adjusted 
to 0.2 mg/ml.  Crosslinking reactions were performed using freshly prepared 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide (EDC)/sulfo-N-hydroxysulfosuccininimide (sulfo-
NHS) stock solutions.  Reactions containing a final concentration of 10 mM EDC/5 mM 
sulfo-NHS were incubated at 0
o
C and reactions containing a final concentration of 
2.5mM EDC/1.25 mM sulfo-NHS were incubated at 23
o
C.  An aliquot from each reaction 
was removed at 30, 60 or 120 min and quenched by addition of 20 mM dithiothreitol 
(final concentration). Each sample was buffer exchanged and concentrated using an 
Amicon Ultra Ultracel 50K filter unit then separated on 3-8% Tris-acetate mini-gels.  The 
bands corresponding to control, crosslinked dimer or crosslinked tetramer samples were 
excised then alkylated and digested with trypsin overnight. 
Construction of Spectrin-Type Domain Template Structures 
 The crystal structure for the β16-β17/α0-α1 region of the mini-spectrin (84) was 
previously solved in our laboratory and therefore used this structure here (PDB: 3LBX). 
For other regions of the mini-spectrin, initial homology models were constructed for 
sequential overlapping  two-domain segments – namely α1-α2, α2-α3, α3-α4, and α4-α5 
– using 4 crystal structures of spectrin-type domains (PBD: 1CUN, 1U5P, 3FB2, and 
1S35) as templates. Sequence alignments were carried out using ClustalW2 (124) with 
default parameters and homology modeling was performed using MODELLER v9.11 
(118-121) with no alterations to the default optimization routine. Ten models were 
generated for each two-consecutive-domain section and the one with lowest average 
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RMSD was selected as the template structure for that section. For the homology 
modeling of closed dimers, crystal structure 3LBX and template structures for α2-α3, α3-
α4, and α4-α5 sections were utilized. The template for α1-α2 was left out to increase the 
degree of freedom at the junction. Every template structure was used in the homology 
modeling of tetramers. Residues at each connector region were manually unaligned in the 
sequence alignments that were input into MODELLER to allow them to adopt a non-α-
helical conformation. Varying the number of unaligned residues in the connector region 
from four to six did not significantly alter subsequent homology models. 
Development of Mini-Spectrin Structures 
 MODELLER was then used to perform homology modeling. Distances between 
crosslinked Cα residues were added as upper bounds for physical distances with a mean 
of 11.0 and a standard deviation of 0.1. Parameters for the optimization and refinement 
routines in MODELLER were tuned to increase model quality. Specifically, optimization 
speed was changed from normal to slow and the maximum number of conjugate gradient 
iterations was set to 300. Molecular dynamics refinement speed was set to very slow. The 
entire optimization-refinement routine was repeated twice before reporting each 
candidate structure. For each mini-spectrin construct (WT tetramer, WT closed dimer, or 
αL207P closed dimer), one hundred models were generated and the model with the 
lowest average RMSD against all others was selected. Because mini-spectrin tetramers 
have mirror-image symmetry through the center of the α2 domains, we opted to generate 
models containing only one half of the molecule plus an additional adjacent α1 and α3 
domains (), and the corresponding symmetry restraints were added to MODELLER. The 
complete tetramer models were assembled by superimposing the corresponding α1-α2-α3 
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sections from two copies of a half-tetramer model in PyMol (125) and stitching them 
together with MODELLER. 
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Chapter 4: Probing Large Conformational Rearrangements 
in Mini-Spectrins Induced by Hereditary Elliptocytosis-
Related αL207P and αL260P Mutations 
 Hereditary elliptocytosis-related mutations weaken the erythrocyte membrane 
cytoskeleton, resulting in deformed red cells and causing hemolytic anemia in severe 
cases. Most of the known mutations can be found in the immediate vicinity of the 
spectrin tetramerization site (α0-β17 domains) and directly disrupt tetramer formation. 
However, distal mutations such as αL207P and αL260P in the α2 domain are located 
more than 70 Å away from the tetramerization site and destabilize spectrin tetramers 
through unknown mechanisms. In this chapter, we applied our chemical crosslinking 
strategy to mini-spectrin constructs containing αL260P or α207P point mutations in order 
to probe the induced conformation rearrangements and elucidate the mechanisms 
underlying how these mutations destabilized red cell membranes. A number of mutant-
specific crosslinked peptides were observed, almost all localized in or near the α2 domain 
and many crosslinked residues were very long distances apart (> 30 Å) on the 
corresponding wild-type structures, indicating substantial conformational rearrangements 
in this region. As far as inter-domain crosslinks, which are informative for subsequent 
homology modeling, are concerned, both mutant tetramer datasets contain identical lists 
of crosslinks. This suggests that the molecular structures of both mutant tetramers are 
very similar. As for the dimers, the α207P mutant dimer datasets contain all inter-domain 
crosslinks observed in the α260P dimer dataset plus additional crosslinks suggesting 
similar but more severe conformational changes for the α207P construct. Hence, a 
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medium-resolution homology model of αL207P mini-spectrin dimer satisfying both 
crosslink-derived distance constraints and independent biophysical measurements was 
developed. The combination of chemical crosslinking, homology modeling, and 
supporting biophysical experiments illustrated how these mutations destabilized tetramer 
formation by resulting in more-compact, most likely more-stable closed dimers. 
4.1 Introduction 
 Inherited disorders of the red cell membrane including hereditary elliptocytosis 
(HE) and the more severe hereditary pyropoikilocytosis (HPP) are in many cases the 
result of a single point mutation in either α- or β-spectrin (93). Most known HE and HPP 
mutations are in the tetramer binding site region, that is, either α0 or β17, and inhibit 
spectrin tetramer formation through disruption of salt bridges, hydrophobic interactions, 
or H-bonds (94). However, in some cases, pathogenic mutations are located 70 Å or more 
from the tetramer site and are thought to exert destabilizing effects on tetramer formation 
through poorly defined long-range effects (93, 95-96). Some of these mutations, 
particularly several common HE/HPP α-spectrin mutations, introduce a proline residue 
and map in or near predicted linker regions connecting adjacent domains. A previous 
study (96) using a recombinant protein containing α0-α5 domains showed that the 
αQ471P mutation, which is located adjacent to the connector region between α4 and α5 
domains, did not have any effect on the tetramer binding site in a univalent binding assay. 
However, changes in thermal stability and cysteine accessibility showed that αQ471P 
decoupled and greatly reduced thermal stability of α4 and α5 domains and suggested that 
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at physiological temperature these domains prematurely unfolded under moderate tensile 
stress, resulting in destabilization of tetramers and the erythrocyte membrane (96). 
 In this chapter, we evaluated structural and functional properties of αL207P and 
αL260P, which are very common HE/HPP mutations (93). Because the αL260P mutation 
was located in an analogous structural position within spectrin domains to the αQ471P 
mutation (FIGURE 1-12), we hypothesized that a similar mechanism would contribute to 
destabilization of spectrin tetramers and red cell membranes. Surprisingly, initial results 
indicated a different mechanism was involved, and, therefore, a detailed evaluation of the 
αL260P mutation was pursued using a mini-spectrin construct previously developed in 
our laboratory (92). The αL260P mutant protein showed only minor perturbations to 
structural properties and exhibited normal tetramerization properties. However, it showed 
reduced capacity to form tetramers, suggesting that perturbations in the closed dimer-
open dimer equilibrium played an important role in tetramer assembly. Similar structural 
characteristics and a lower propensity to form tetramer were observed when the αL207P 
mutant protein was investigated. Chemical crosslink analyses revealed mutant-specific 
crosslinks in the vicinity of either mutation for both dimers and tetramers, indicative of 
large conformational rearrangements that suggest increased flexibility for the mutant 
tetramers and more-compact structures for the mutant dimers. Biophysical experiments 
were also performed which provided independent confirmation for the aforementioned 
observations. Taken together, we concluded that both mutations shift spectrin dimer-
tetramer equilibrium toward closed dimers by simultaneously destabilizing tetramer 
structure and gave rise to a more-compact, most likely more-stable closed dimer 
conformation, thus shifting spectrin dimer-tetramer equilibrium toward closed dimer. 
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4.2 Results 
4.2.1 Effects of αL207P and αL260P Mutations on Tetramer Assembly 
 Thermal stability and secondary structural characteristics of the wild-type and 
mutant mini-spectrin tetramers were determined using differential scanning calorimetry 
(DSC) and circular dichroism (CD). DSC scans of the wild-type tetramers revealed 2 
major transitions, one with a Tm at 48
o
C and a second peak at 58
o
C, which had been 
previously shown (96) to correspond to the melting temperature of α4-α5 and α1-α2-α3 
domains, respectively. Scans of both mutant tetramer constructs showed a very similar 
first thermal transition at 48
o
C but decreases in melting temperatures and distinctive 
reductions in enthalpy for the second peak (FIGURE 4-1). Hence, the most likely 
interpretation is that these mutations only destabilize the local α1-α2-α3 region and there 
are minimal, if at all, perturbations of the α4-α5 domains that are further away. 
Additionally, circular dichroism data showed an almost identical helical content for the 
wild-type and mutant proteins, indicating that there are no significant changes in the 
secondary structures. 
Previously, analysis of the mini-spectrin dimer-tetramer equilibrium by 
sedimentation equilibrium at 30
o
C confirmed an identical association affinity to that of 
full length spectrin purified from fresh human erythrocytes with a dissociation constant 
(Kd) of 1 μM (126-127). In the current study, wild-type and mutant dimer-tetramer 
equilibria were evaluated in parallel using sedimentation equilibrium at 30
o
C. 
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FIGURE 4-1 Differential scanning calorimetry. 
The first peak corresponds to the melting point of α4-5 domain at around 48oC and the 
second to that of α1-3 region at about 58oC. Peak height represents thermal stability of 
the domain. 
 
The Kd of 1 M for the wild-type protein was re-confirmed and Kd’s of 5 μM and 11 μM 
was determined for αL260P and αL207P respectively, indicating a 5-fold and 11-fold 
decrease in binding affinity for tetramer formation. The dimer-tetramer interaction was 
further examined using an HPLC gel filtration assay where samples were incubated at 
37
o
C to achieve equilibrium under physiological conditions, followed by a separation by 
gel filtration at room temperature. Purified dimer or tetramer fractions from each mini-
spectrin construct were injected onto the HPLC column after incubation at 37
o
C.  In all 
cases, equilibrium was achieved within 45 minutes, indicating that the kinetics of 
association were indistinguishable from full length spectrin (83), and the final dimer-
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tetramer ratios were the same regardless of whether the sample was initially all tetramers 
or all dimers, as expected for a reversible equilibrium. Consistent with the lower apparent 
Kd observed in the sedimentation equilibrium experiments, both mutants predominantly 
adopt dimer conformations compared to the wild-type equilibrium (FIGURE 4-2). 
 CX-MS analyses of the wild-type and mutant mini-spectrin tetramers revealed 
that all of the crosslinked peptides observed in wild-type tetramers were also found in 
both αL207P and αL260P mutants. In addition, unique crosslinks were found for the 
mutant constructs, most of them localized in the neighborhood of the α2 domain where 
both mutation sites are located. Interestingly, all mutant tetramer-specific inter-domain 
crosslinks are also identical for both mutants, suggesting that the molecular structures for 
both mutant tetramers might be very similar or are at least indistinguishable at this level 
of analysis. These crosslinks are summarized in TABLE 4-1 and three of them 
crosslinked residues that are 43-76Å apart in the wild-type protein (FIGURE 4-3A). The 
wild-type tetramer structure developed in Chapter 3 was used as a template for modeling 
structural changes indicated by these crosslinks. Unfortunately, it was not possible to 
derive a single consensus structure for either mutant that satisfied the distance constraints 
for all crosslinks simultaneously without extensive perturbation to the general three-
helix-bundle motif. A representative ensemble of mutant structures is summarized in 
FIGURE 4-3B, C, and D. Distances between the α-carbons of crosslinked residues for 
these models are shown in FIGURE 4-3E. These data indicate that the region in the 
vicinity of the mutation is flexible and dynamic, as it most likely adopts multiple 
alternative conformations. All of these conformations preserve the high helical content, 
indicated by the CD measurements, and all conformations involve a large kink between 
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FIGURE 4-2 Analytical gel filtration. 
The first peak corresponds to tetramers and the second to the dimers. The shift of mutant 
dimers to a later retention time is indicative of a smaller hydrodynamic radius. LEFT: 
Isolated mini-spectrin dimers were used as starting material. RIGHT: Isolated tetramers 
were used as starting material. Both types of starting sample reached the same 
equilibrium and both mutant dimers are remarkably smaller than the wild-type molecular 
shape. 
 
ID Peptide Sequence
 a
 Domains Charge MH+ 
1 AHI(EE)LR-HEAFE[K]STASWAER 1C-17B 4 2497.222 
2 HEIDSY(DD)R-YQ[K]HQSLEAEVQTK 4B-1B 4 2819.323 
3 FQSADETGQ[D]LVNANHEASDEVR-TEVLH[K]K 4B-2B 4 3367.615 
4 T[E]VLHK-AE[K]LTLSHPSDAPQIQEM#K 2B-3B 4 2846.472 
5 T[E]VLHK-ELCA[K]AEK 2B-3B 3 1655.878 
6 DA(DD)LGK-AE[K]LTLSHPSDAPQIQEM#K 1A-3B 4 2853.393 
 
TABLE 4-1 αL207P and αL260P mutant tetramer-specific crosslinks. 
All crosslinks listed here are common between the αL207P and αL260P mutant tetramers.  
a
 [ ] indicates crosslinked residue; ( ) indicates ambiguous assignment crosslinked 
residue; # indicates oxidized methionine. 
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α2 and α3 that reduces the hydrodynamic radii of the mutant tetramer molecules 
compared to the wild-type protein. 
4.2.2 Homology Modeling of αL207P Closed Dimer 
Available biophysical data suggested that both αL207P and αL260P mutations 
affect the dimer structure in a similar manner, with similar smaller hydrodynamic radii, 
reduced thermal stability of the α1-α2-α3 region, and reductions in apparent 
tetramerization affinity of about 5 and 11 folds for αL260P and αL207P, respectively. 
Indeed, crosslink data provides further evidence that the αL207P mutation induces 
analogous but more severe conformational changes of closed dimers compared to 
αL260P (FIGURE 4-4), as the αL207P datasets contain all inter-domain crosslinks found 
in αL260P plus additional ones. Hence, for the purpose of developing a mutant closed 
dimer model to understand the effect of these HE-related mutations, we focused the rest 
of our structural analyses in this section on the αL207P mutant.  
While sedimentation equilibrium analysis showed that the αL207P mutation shift 
the dimer-tetramer equilibrium toward dimers, univalent binding assays of either the 
wild-type or the αL207P mutant α1-5 domain with wild-type β16-17 yielded identical 
binding with Kd’s of 0.5 µM. The latter assay involves only the univalent head-to-head 
tetramer association, and therefore shows that this mutation does not directly affect the 
binding of the α0 and β17 domains. This is not surprising as the mutation is a large 
distance from the binding site. In contrast, the reduced binding affinity of αL207P in the 
mini-spectrin construct suggests that the capacity of this larger form of the molecule to 
form closed dimers is responsible for the observed reduced apparent tetramer affinity. 
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(See figure caption on the next page) 
FIGURE 4-3 Long-range crosslinks unique to the mutant tetramer. 
94 
 
(A) Location of three mutant tetramer-specific long-range crosslinks and their Cα-Cα 
distances on the wild-type structure are indicated. Crosslinked side chains are presented 
with spheres (blue = Lys, red = Glu or Asp). (B) The model shown in orange was derived 
by applying the distance constraint defined by crosslink #1 (43 Å in panel A). Light cyan 
is the wild-type tetramer model. (C) The model shown in blue was derived by applying 
the distance constraint defined by crosslink #2 (76 Å in panel A). (D) The model shown 
in red was derived by first applying crosslink #2 (76 Å in panel A) followed by crosslinks 
#1 (43 Å in panel A) and #3 (61 Å in panel A). (E) The distances between α-carbons for 
six mutant tetramer specific crosslinked residues on the models shown in panels A-D. 
The horizontal line at 12Å defines the expected maximum distance between α-carbons 
for zero-length crosslinks. The bars are color coded according to the source structures. 
 
 
 
FIGURE 4-4 Mini-spectrin closed dimer inter-domain crosslinks. 
(A) Inter-domain crosslinks found for the wild-type mini-spectrin closed dimer. (B) 
Crosslinks from the αL260P mutant dimer datasets. (C) Crosslinks from the αL207P 
mutant dimer datasets. Asterisks indicate approximate locations for the mutation sites. 
Blue crosslinks are common to all (wild-type and both mutants). Red crosslinks are 
mutant-specific but common to both mutants. Black crosslinks are unique to the αL207P 
mutant dimers. 
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Interestingly, while analytical gel filtration revealed that the αL207P dimers exhibited a 
slightly smaller hydrodynamic radius (FIGURE 4-5A), CD analysis showed that the α-
helical content, and therefore the overall secondary structures, were largely unperturbed 
(FIGURE 4-5B). 
When αL207P dimers were crosslinked using the same conditions as the wild-
type dimers, all inter-domain crosslinks observed in the wild-type protein plus six new 
mutant-specific crosslinks were identified (FIGURE 4-5C). Five of these crosslinks 
occurred between residues that were 28-45Å apart on the wild-type closed dimer model 
(FIGURE 4-5D) indicating that major conformational rearrangements occurred between 
the α1, α2, and α3 domains of the mutant. Using the wild-type closed dimer structure 
developed in Chapter 3 as a starting template, a mutant closed dimer structure was 
derived (FIGURE 4-5E) by applying all 19 crosslinks shown in FIGURE 4-5C. One 
hundred candidate models were generated, which clustered tightly with average pairwise 
RMSD of 3.52 Å. Consistent with the gel filtration data, the mutant dimer model is more 
compact than the wild-type counterpart. Comparisons of Cα-Cα distances for the 19 
crosslinks when mapped onto the wild-type and mutant closed dimer structures (FIGURE 
4-5F) shows that conformational changes were limited to the hairpin loop involving α1, α2, and 
α3. 
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FIGURE 4-5 Structure of the αL207P mutant dimer. 
(A) HPLC gel filtration analysis of wild-type and αL207P mini-spectrin. (B) 
Representative circular dichroism data for wild-type and αL207P mini-spectrin dimers. 
(C) Locations of αL207P inter-domain crosslinks compared to wild-type’s; asterisk – 
location of αL207P mutation. (D) Locations of five αL207P mutant-specific crosslinks 
indicative of conformational rearrangements in the α1-α2-α3 region shown on the wild-
type structure; blue – Lys; red – Glu/Asp, black–Pro mutation, black lines – crosslinks 
with Cα-Cα distances labeled. (E) Refined model of the αL207P mutant closed dimer. (F) 
Cα-Cα distances for inter-domain crosslinks identified in the αL207P mutant dimer on 
the wild-type and αL207P closed dimer structures. 
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4.3 Discussion 
 Due to the very large size of full length spectrin polypeptide chains, structural and 
functional analyses of hereditary hemolytic anemia associated single point mutations 
using mutagenesis of the full length recombinant protein are impractical. Therefore, a 
mini-spectrin recombinant protein was developed in our laboratory as a template to study 
properties of the open-closed dimer equilibrium and the bivalent dimer-tetramer 
equilibrium. Previous analysis has shown that this construct effectively mimicked 
properties of full length spectrin. This template was used in this dissertation to evaluate 
the common HE-related mutations, namely αL207P and αL260P. Interestingly, while 
univalent tetramer binding assays exhibited identical binding affinity at the 
tetramerization site for wild-type and mutant constructs, sedimentation equilibrium and 
analytical gel filtration of mini-spectrins showed large decreases in mutant tetramer 
formation. This is consistent with previous analysis of full length spectrin isolated from 
patients with these mutations, which showed decreased amounts of spectrin tetramers 
(128). These data suggest that perturbations in the mutant protein structures affect the 
closed-open dimer equilibrium, resulting in reduced tetramer formation. 
Since all crosslinks observed in wild-type mini-spectrin tetramers were also found 
in both αL207P and αL260P mutants, it is very likely that most of the tertiary structure of 
the tetramer molecules is unaffected by either mutation. Furthermore, as all mutant 
tetramer-specific inter-domain crosslinks were also identical between the two mutants, 
we conclude that both mutations have very similar effects on the tetramer structures that 
are at least indistinguishable at the current level of analysis. Most of these mutant-
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specific crosslinks localized to the neighborhood around the mutation sites in the α2 
domain and three of them involved residues that are far apart on the wild-type structure 
(~40-70 Å). These latter crosslinks indicate that both Leu-to-Pro mutations introduce 
kinks in the α1-α2-α3 region and allow each protein to fold back upon itself without 
major perturbation to most of the secondary and tertiary structures. The inability of 
subsequent homology modeling to generate a single consensus model that simultaneously 
satisfied all three mutant-specific inter-domain crosslinks further suggests that the 
increased molecular flexibility induced by the mutations allow the mutant tetramers to 
adopt multiple conformations. 
As for the dimers, CX-MS analyses clearly showed that the αL207P mutant 
dimers exhibit more severe structural perturbations with unique crosslinks indicating 
tighter lateral association between the α1 and α2-α3 domains (FIGURE 4-4). Therefore, 
subsequent modeling analyses were focused on the αL207P mutant dimers alone. Overall, 
three mutant-specific crosslinks between the α1 domain and the neighborhood around the 
α2-α3 junction (FIGURE 4-5C, D) indicate the collapse of this α1-α2-α3 hairpin region, 
thereby supporting the observation of more-compact mutant dimer molecules (FIGURE 
4-2). Two mutant-specific crosslinks between the α2 and α3 domains also indicate 
moderate rotation and reorientation of these two domains relative to each other, possibly 
to create a tighter association interface between them and the α1. In addition to the inter-
domain crosslinks used to model the αL207P closed dimers, four crosslinks within the α2 
domain were also identified (TABLE 4-2), which suggest that this region also undergoes 
localized conformational rearrangements. One model that could explain these crosslinks 
is the sliding of the A-, B-, and C-helices in the α2 domain relative to each other, with 
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mechanisms similar to those illustrated in (129). However, MODELLER tends to 
introduce bends in the middle of individual helices to fit the input distance constraints, 
and it is currently unclear whether the distortions of the helical structures or the sliding of 
helices actually occurred. In summary, the αL207P mutation induces the collapse of the 
α1-α2-α3 hairpin region that most likely results in tighter, presumably more-stable lateral 
association in the mutant closed dimers. Notably, an open dimer-specific crosslink was 
absent from every αL207P crosslinked sample, even when reactions were performed at 
room temperature. This is significant because wild-type dimers are primarily in the open 
dimer state at or above room temperature. This suggests that αL207P dimers 
preferentially form closed dimers. Thus, all evidences point toward the hypothesis that 
these mutations shift the spectrin dimer-tetramer equilibrium toward closed dimers by 
stabilizing the closed dimer conformation. 
 It is intriguing that although αQ471P and αL260P mutations are located at the 
equivalent location on the three helix bundle structure (FIGURE 1-12), they destabilize 
spectrin tetramers and red cell membranes by remarkably different mechanisms. As 
previously shown, the αQ471P mutation destabilizes the thermal and tensile stress 
stability of the α and α domains (96). In contrast, we have shown here that the αL260P 
mutation gives rise to a more-compact, more-stable closed dimer structure that alters the 
dimer-tetramer equilibrium.  These mechanisms are consistent with the observations that 
both mutations show normal affinity in univalent tetramer binding assays, while the 
αL260P mutation alone shows reduced tetramer association in sedimentation equilibrium 
experiments. As illustrated, the closed-open dimer equilibrium involves flexing of hinges 
and other conformational rearrangements between the α, αand α3 domains. 
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Charge MH+ Sequence 
Cα-Cα 
Distance
a
 (Å) 
3 3122.532 EAIATSV[E]LGEDWER-[K]FEDFQVEPVAK 12.2 
4 2603.358 FE[D]FQVEPVAK-Q[K]ALSNAANLQR 14.2 
4 3659.773 FQQYVQECADIL[E]WIGDK-[K]FEDFQVEPVAK 21.5 
4 3077.54 FQQYVQ(E)CA(D)ILEWIGDK-TEVLH[K]K 26.6 - 31.2 
 
TABLE 4-2 αL207P mini-spectrin dimer-specific crosslinks located within the α2 
domain. 
a
 Distances shown here were calculated based on the wild-type closed dimer model. 
 
Hence, changes in structure induced by the αQ471P mutation located in the α- junction 
are outside the region most affected by this closed-open dimer inter-conversion. In 
contrast, the αL207P and αL260P mutations are located right in the middle of this α-α2-
α3 region.  
4.4 Material and Methods 
Crosslink data analyses were carried out as described in Chapter 2. 
Expression and Purification of Recombinant Mini-Spectrin Proteins  
 The expression and purification of the wild-type construct used in this study has 
been described previously (92) and briefly outlined in Chapter 3. Site directed 
mutagenesis was used to introduce the HE-associated mutations αL260P or αL207P into 
the alpha spectrin portion of the mini-spectrin construct using standard methods. The 
purification of the mutant proteins followed the same procedure as the wild-type protein. 
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Differential Scanning Calorimetry 
 Thermal stability of mini-spectrin constructs was evaluated using an MCS 
differential scanning calorimeter (MicroCal, Northampton, MA).  Purified mini-spectrin 
tetramer constructs were exhaustively dialyzed against 10 mM sodium phosphate, 130 
mM sodium chloride, 1 mM TCEP pH 7.4.  The protein concentration was adjusted to 0.5 
mg/ml then degassed for 5 min prior to loading in the sample cell.  The reference cell 
contained degassed buffer.  Scans were performed over the temperature range 20 to 90
o
C 
using a scan rate of 0.5
o
C/h.  After subtraction of the buffer baseline and normalization 
based on protein concentration, data analysis was performed using the Origin version 3.2 
program provided with the instrument.  Curves were smoothed using a 5 point FFT 
smoothing filter available within the Origin software. 
Circular Dichroism 
 Secondary structure determination was performed using a Jasco J-810 Circular 
Dichroism Spectrapolarimeter (Jasco, Sydney, Australia) using 0.1 cm cuvettes. The 
temperature controller was set to 20
o
C.  Four scans were averaged then buffer baseline 
corrected.  All sample concentrations were determined using the optical density at 280 
and the intrinsic extinction coefficient (determined from protein composition) and were 
in the range 15-20 μM.  Samples were dialyzed into buffer containing 20 mM sodium 
phosphate, 130 mM sodium fluoride, and 0.1 mM TCEP pH 7.4. 
Sedimentation Equilibrium 
 Wild-type and mutant tetramers and dimers were analyzed by sedimentation 
equilibrium using a Beckman XL-I analytical ultracentrifuge.  All samples were isolated 
by gel filtration chromatography using two BioAssist G4000 SWXL columns connected in 
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series and equilibrated in 20 mM Tris, 130 mM NaCl, 1 mM EDTA, 0.15 mM PMSF, 1 
mM TCEP pH 7.4 and maintained at 4
o
C.  The cells were assembled with 12 mm epon 
double sector Yphantis-style centerpieces and sapphire windows. The loading volume 
was 110 l for both sample and reference buffer.  Samples were analyzed at 30oC using a 
minimum of two different rotor speeds.  Data were collected at three different initial 
loading concentrations for each sample and analyzed as previously described (92).  
Univalent Binding Assay 
 Thermodynamic binding analysis was determined using a VP-ITC isothermal 
titration calorimeter. Binding parameters for the formation of univalent head-to-head 
tetramer type interactions were determined using the wild-type 16-17 construct and 
either the wild-type α0-5 or mutant α0-5 recombinant construct.  Binding reactions were 
performed at 23
o
C in 10mM sodium phosphate, 130mM sodium chloride, 1 mM 2-ME 
pH 7.4.  Samples were exhaustively dialyzed and degassed prior to loading the sample 
cell or syringe. The reference cell contained dialysis buffer. A series of 26 10l injections 
spaced 40 min apart were made using a stirring rate of 300 rpm. A control titration 
containing protein in the syringe and buffer in the sample cell was performed and used to 
correct for heat of dilution. Data analysis and curve fitting was performed using MicroCal 
Origin 5.0 software provided with instrument. 
Analytical Gel Filtration 
 All samples were isolated and evaluated by gel filtration chromatography using 
two G4000SWXL BioAssist columns (Tosoh Corp., Tokyo, Japan) connected in series.  
The columns were equilibrated in 10 mM sodium phosphate, 130 mm NaCl, 1 mM 
EDTA, 0.15 mM PMSF, 1 mM TCEP pH 7.0 and maintained at ambient temperature.  
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After initial isolation of the tetramer or dimer peak, the sample was diluted to 0.05 mg/ml, 
then 100 pmol was re-injected immediately or incubated at 37
o
C and re-injected at 45 
min intervals.  
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Chapter 5: Conclusions and Future Directions 
5.1 Conclusions 
 This dissertation presents a robust MS data acquisition and computational data 
analysis strategy for identifying zero-length crosslinked peptides that integrates the 
benefits of label-free comparison and targeted MS to effectively filter out non-crosslink 
background signals and efficiently acquire high-resolution MS/MS data. Most 
importantly, the use of high-resolution MS/MS data greatly increases the confidence of 
crosslink identification while maintaining good depth of analysis. The dedicated software, 
ZXMiner, compares very favorably with existing crosslink analysis software tools, 
producing more true positive identifications at lower false discovery rates. Also, 
ZXMiner greatly reduces data analysis time from several weeks or months to a day or 
less and removes the need for manual evaluation of MS/MS spectra. The current pipeline 
was successfully trained and validated on a 17 kDa monomer and a 52 kDa homodimer 
with known crystal structures and was later applied to five larger systems, including 
mini-spectrin dimers (90 kDa), mini-spectrin tetramers (180 kDa), full-length spectrin 
heterodimers (526 kDa), isolated membrane cytoskeletons (> 1 MDa), and intact red cell 
membranes (> 2 MDa). The three latter systems represent the largest zero-length 
crosslinking problems analyzed to date. 
 The improvements in zero-length crosslink identifications resulted in increased 
numbers of distance constraints that permitted subsequent homology modeling of wild-
type mini-spectrin dimers and tetramers as well as structures for the αL207P and αL260P 
105 
 
mutant mini-spectrins. More than a dozen distance constraints covering every region of 
the molecule were satisfied in each of the derived medium-resolution structures. 
Comparative analysis between wild-type and mutant mini-spectrin constructs revealed 
large but local conformational rearrangements, located within the domains immediately 
adjacent to the mutation sites. These structures are in good agreement with observations 
from multiple independent biochemical and biophysical experiments. To summarize, the 
combination of chemical crosslinking, homology modeling, and supporting biophysical 
experiments illustrated how these common HE-related mutations destabilized tetramer 
formation by producing more-compact, apparently more-stable closed dimers. Our results 
highlight the power and applicability of zero-length chemical crosslinking coupled with 
mass spectrometry for probing protein structures and large conformational changes in 
large protein complexes. 
5.2 Future Directions 
5.2.1 Further Improvements to the Crosslink Analysis Strategy 
Results described in Chapter 2 emphasize the advantage of obtaining high-
resolution MS/MS information, which requires multiple LC-MS/MS runs and an 
increased amount of crosslinked sample compared with single analyses when using a 
hybrid instrument such as the LTQ Orbitrap XL. But a much higher density of crosslinks 
can be obtained as a result, which is very valuable when verifying and refining homology 
and protein-protein docking models. In addition, recent development of a new generation 
of mass spectrometers capable of very rapid acquisition of high-resolution MS/MS 
spectra such as the Q Exactive (Thermo Scientific) (130) can accommodate our data 
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acquisition strategy with a reduced need for parallel targeted LC-MS/MS runs. 
Preliminary analyses using linear peptide samples showed that the Q Exactive possesses 
greater sensitivity over current instruments and can obtain high-resolution MS/MS 
spectra 20 times faster. For example, only 30 ms are required for a Q Exactive to acquire 
a high-resolution MS/MS scan, compared to 600 ms on an LTQ Orbitrap XL (comparison 
was made at 17,500 resolution on the Q Exactive and 15,000 on the LTQ Orbitrap XL). 
This boosted high-resolution MS/MS spectra acquisition rate will also make it practical to 
analyze more crosslinking samples using multiple proteases and upstream fractionation 
techniques (69), which are approaches that have been shown to greatly increase the 
number of crosslinked peptide identifications. 
However, the Q Exactive utilizes a distinct fragmentation technique called higher-
energy collisional dissociation (HCD), resulting in MS/MS spectra with suppressed b-ion 
signals and other subtle differences compared to those produced from collision-induced 
dissociation (CID) method that is employed in the LTQ Orbitrap XL. To account for the 
changes in fragmentation preferences, crosslinking experiments of standard proteins, 
GST and myoglobin, need to be re-analyzed on the Q Exactive to update and re-optimize 
all the parameters involved in evaluating MS/MS data. Unfortunately, a current 
stumbling block is that most available label-free analysis software tools either only 
perform the analysis post-identification and consider only identified linear peptide signals 
or cannot handle data generated from the Q Exactive. Hence, implementation of a new 
label-free comparison tool is also required for migrating the current pipeline to the Q 
Exactive instrument. Another rationale for needing a new label-free analysis tool is that 
our current software, Rosetta Elucidator, is a commercial product that is now outdated 
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and no longer supported. Currently, we have developed a preliminary label-free analysis 
software tool that mimics the strategy and algorithm described in (67) and can analyze 
data from the Q Exactive. Test results on several crosslinked and linear peptide samples 
suggest that this software is effective. However, further validations are needed to confirm 
the generalizability and capability of this new tool before it can be integrated into the 
pipeline. 
A complication that can arise when annotating MS/MS spectra is interference 
from co-eluting precursors with similar m/z to the crosslinks of interest. Unexpected 
peaks from contaminating precursors not only lower the quality scores of true crosslinks 
but also potentially cause misidentifications. Although such MS/MS spectra could 
theoretically be treated as mixtures of multiple peptides and de-convoluted (131-132), 
further increasing the complexity of crosslink identification is undesirable and is most 
likely impractical. Instead, a possible extension of our pipeline which can alleviate the 
interference issue is to add an MS3 data acquisition stage for targeted crosslink 
candidates with borderline quality score and those whose corresponding full MS scans 
reveal existence of interfering ions within the specified isolation width. Since specific 
fragmented b- or y-ions of the crosslinks of interest in the MS/MS spectra under 
investigation can be targeted for further fragmentation, any ion contributions from 
interfering precursor signals should disappear in the resulting MS3 spectra. Furthermore, 
readily available annotated MS/MS spectra from ZXMiner provide a quick and easy way 
to select abundant b- and y-ions for MS3 analyses. We have successfully performed a 
pilot MS3 experiment to verify a few questionable crosslink assignments in mini-spectrin 
tetramer samples. One drawback of this approach is the fact that the signal to noise ratios 
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in MS spectra greatly worsen with each fragmentation step. This is because yields of 
trapping and fragmenting ions are incomplete at each step, and crosslinked peptide 
signals often already start at relatively low intensity levels. Hence, MS3 spectra of 
crosslinked peptides can easily disappear into the noise level. As such, the major way of 
overcoming this issue is to push the mass spectrometer to the limit in terms of injecting a 
heavy load of the peptide digest to boost the targeted signal intensity as much as possible. 
5.2.2 Application of the Crosslink Analysis Strategy to the Red Cell Membrane  
While the CX-MS analysis strategy described in this dissertation is capable to 
achieving high-confidence crosslink identifications with low FDR regardless of protein 
complex sizes, without additional experimental steps, the depth-of-analysis declines 
rapidly as the protein complex size increases. This is due to two limiting factors of the 
mass spectrometer instruments. First, only up to a certain amount of peptide content can 
be analyzed in each LC-MS/MS run (e.g. about 1µg when 75µm ID columns are used) 
without inducing distortions in the chromatographic profile. Hence, as protein complex 
size increases, the number of molecules of a specific crosslinked peptide that can be 
analyzed in a single run decreases, resulting in reduced crosslinked peptide signal 
intensities. Second, high-resolution mass analyzers such as the Orbitrap require minimum 
peptide signal intensities in order to generate good-quality MS/MS spectra. In our case, 
the signal intensity threshold was set at 50,000 ion counts. Therefore, if a protein 
complex size increases by 10-fold, the femtomoles of the crosslinked sample that can be 
injected into the mass spectrometer will drop by 10-fold and the signal intensities of 
many crosslinked peptides will fall below the detection threshold. A straightforward 
solution to these limitations is to pre-fractionate the crosslinked peptide sample, basically 
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splitting it into largely non-overlapping portions in terms of peptide content. This method 
allows larger amounts of crosslinked peptides to be analyzed at the penalty of an 
increased number of LC-MS/MS runs. It is important to note here that the fractionation 
technique required here is fundamentally different from those described in (68-69), as the 
main purpose here is to distribute crosslinked peptides across fractions as uniformly as 
possible. Preliminary fractionation efforts using red cell membranes crosslinked with 
EDC confirm that this strategy can greatly improve the depth of analysis for very 
complex samples.  
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